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 The United States population experienced an increase of 75% in the 
prevalence of asthma from 1980 to 19941.  Distant countries with similar 
lifestyles, such as the United Kingdom2 and Australia3, reported comparable 
increases in asthma prevalence during this period of time.  Currently, in the 
United States, Canada, United Kingdom, Ireland, New Zealand and Australia, the 
prevalence of allergic airway disease among 13-14 year old children is among 
the highest in the world and ranges from 22-32%4. In response to these 
developments, the International Study of Asthma and Allergies in Childhood 
(ISAAC) was initiated with a stated goal to determine the prevalence of allergic 
disorders in children living throughout the world using standardized criteria, 
increasing comparative value.  The Phase I survey of 450,000+ children in 56 
countries revealed stark geographic differences in prevalences5.  The pattern 
and magnitude of variation throughout the world suggest that environmental 
factors are critical to the development of allergies in childhood.  Upon further 
evaluation of the ISAAC and the European Community Respiratory Health 
Survey (ECRHS) of asthma prevalence in adults, several trends became 
apparent including (1) an increase in allergy prevalence throughout the world, (2) 
a pattern of asthma prevalence where it is more common in Westernized 
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countries and less common in developing countries, and (3) an increase in 
prevalence as countries Westernize or as communities urbanize6.  
 Allergic responses are a form of hypersensitivity response, where the term 
“hypersensitivity” refers to an adverse state of heightened immune reactivity to 
innocuous antigens.  Allergic diseases are manifested by inappropriate immune 
responses to harmless foreign materials in those with a genetic predisposition. 
The magnitude of the hypersensitivity reaction is out of proportion to the posed 
threat, so these immune responses are unnecessarily injurious to the host.  
Hypersensitivity reactions occur in the pre-sensitized host upon re-exposure to 
the inciting antigen, and they are mediated by T cells and immunoglobulins of the 
adaptive immune system.  Hypersensitivity responses that occur repeatedly can 
result in significant disease.  Indeed, chronic inflammation can lead to severe 
morbidity and mortality. 
 In those with respiratory allergies, hypersensitivity to fungal allergens is 
common.  At least 20-25% of those with asthma are skin-test positive for fungal 
allergens, commonly including Aspergillus fumigatus7, 8.  Moreover, current 
evidence suggests an association between fungal sensitization and asthma 
severity9.  Patients with severe asthma requiring multiple hospital visits were 
significantly more likely to be sensitized to fungal allergens than those with mild 
asthma10.  The true impact of fungi on those with respiratory allergies is not well 
understood, because fungi are ubiquitous but hard to measure and exposure is 
universal but variable with respect to time and intensity. 
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 CD4+ T helper (TH) cells are central regulators of the hypersensitivity 
reaction, because they serve an essential role in the coordination of the adaptive 
immune response.  Separate, distinct subsets of CD4+ TH cells mediate a variety 
of distinct adaptive immune response “programs”.  Antigen, including allergen, 
exposure can initiate the afferent phase of the adaptive immune response that 
includes all subsequent events that lead to the formation of a poised antigen-
specific response.  The priming of CD4+ TH cells from naïve precursor CD4
+ T 
cells is a critical component of the afferent phase.  CD4+ TH cells aid B cells in 
the production of antibodies that mediate components of the hypersensitivity 
reaction.  Endowed with antigen-specific receptors, T cells and antibodies 
mediate the efferent phase of the adaptive immune response that encompasses 
all the immune activities directed at the antigen source.  Pre-formed antibodies 
trigger the immediate hypersensitivity reaction.  Meanwhile, primed T cells 
mediate delayed hypersensitivity responses, mainly through the secretion of 
immune signaling molecules, especially cytokines.  The coordinated immune 
response against the innocuous antigen results in collateral damage to host 
tissue, manifesting as the symptoms of hypersensitivity disease. 
 
Current Hypotheses for the Pathogenesis of Allergies   
After comparing allergic, or atopic, disease prevalence between white and 
Aboriginal families in Saskatchewan, Gerrard and co-workers suggested in 1976 
that atopic disease may be the price paid for freedom from infectious diseases11.  
The “hygiene hypothesis” for allergy gained widespread attention after 
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Strachan proposed in 1981 that a decrease in the episodes of early life infections 
due to increased cleanliness in the home and decreased sibship may underlie 
the increasing incidence of hay fever noted in the UK12.  Prior to the identification 
of additional CD4+ T cell subsets, the TH1/TH2 dichotomy was considered a 
cornerstone of adaptive immunity for decades after it’s inception in the 1980s13.  
It was purported that CD4+ T cells differentiated into either CD4+ TH1 or TH2 cells, 
and each mediated unique immune responses.  Accordingly, the TH1/TH2 
dichotomy was incorporated into explanations for the alarming increase in the 
prevalence of allergic diseases, including atopic asthma, noted in the latter half of 
the 20th century in developed countries1.  The “hygiene hypothesis” for allergies 
stated that a paucity of TH1-promoting infections early in life disrupted the 
TH1/TH2 balance and resulted in an increased propensity for developing TH2-
mediated allergies11, 12.  
The depth of the collective understanding of immune regulation has 
been greatly increased during the intervening period through revelatory work on 
the biology of CD4+ T regulatory cells (TReg) and certain dendritic cell (DC) 
subsets with regulatory function.  Furthermore, the identification of pattern 
recognition receptors (PRRs) including the Toll-like receptor (TLR) family has 
further illuminated the expansive ability of cells of the immune system to interact 
with the microbial world in order to achieve an appropriate immune response.  
This type of information regarding immune regulation taken together with 
accumulated epidemiological evidence concerning the association between 
environmental factors and diseases of immune dysregulation, has lead to a 
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refashioning of the original “hygiene hypothesis”.  A revised understanding of the 
hypothesis should encompass the idea that alterations in certain interactions with 
the microbial world in general, and not infections in particular, in Westernized 
countries has led to defects in the maintenance of immune regulation resulting in 
an increase in the incidence of allergic, and possibly autoimmune disease14, 15.  
 Rook and Burnet suggest that nonpathogenic microbes which have 
shared human’s evolutionary past are recognized by the innate immune system 
and instruct the development of immunoregulatory responses that inhibit allergic 
disorders, autoimmune disease, and inflammatory bowel disease16, 17.  Bjorksten 
contends that no major risk factors leading to the development of allergies have 
been identified, but rather that recent evidence indicates a deficit in the protective 
influence of interactions with the intestinal microbiota during infancy may be 
leading to the increase in allergic disease18.  There is a significant amount of 
epidemiologic and clinical data supporting this altered microbiota hypothesis.  
These include correlations between allergic airway disease and (1) altered fecal 
microbiota, (2) antibiotic use early in life, and (3) dietary changes over the past 
two decades (reviewed in19). 
 
Mucosal Immune System 
The mucosal immune system monitors the epithelium of the respiratory, 
gastrointestinal, and genitourinary tracts, where vital interactions with the outside 
world are undertaken. The mucosal immune system is charged with guarding the 
epithelial surfaces to protect the host against infection, but inappropriate 
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inflammation can damage the epithelium and impair important physiologic 
functions.  For this reason, tolerance and inflammation are tightly controlled by 
complex, multi-layered regulatory mechanisms along the mucosa.  Many features 
of the mucosal immune system commensurate with this task have been 
identified, including unique epithelial cells and innate and adaptive immune cells.  
Similarities in the structure and function of different musoca-associated lymphoid 
tissues (MALT) have encouraged the concept of a common mucosal immune 
system (CMIS), but differences do exist.  A shared property is the propensity to 
generate systemic tolerance to antigens encountered via the oral, nasal, and 
airway routes20-23. 
MALT is organized into unique inductive and effector sites24, 25.  Inductive 
sites include specialized lymphoid follicles underlying the epithelium, such as 
nasopharynx-associated lymphoid tissue (NALT) and bronchial-associated 
lymphoid tissue (BALT) in the upper and lower airway, respectively, and Peyer’s 
patches (PP) and isolated lymph follicles (ILF) in the gut, and downstream lymph 
nodes, including cervical and mediastinal lymph nodes (LN) draining the 
respiratory mucosa and mesenteric LN draining the intestinal mucosa.  MALT 
effector sites include the epithelium and lamina propria.   
The lungs are comprised of two functionally distinct compartments, the 
conducting airways and the lung parenchyma26.  The conducting airways are 
lined with mucosal epithelium, containing ciliated and secretory cells that 
together mediate the mucociliary clearance of inhaled antigens.  The lung 
parenchyma is composed of the thin-walled alveoli that are specialized for the 
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purpose of gas exchange between the inhaled air and underlying capillaries.  The 
regulation of inflammation in the lung parenchyma is critical in order to protect 
the host and to permit gas exchange.  In addition to antigen exclusion and 
mucociliary clearance, airway epithelial cells secrete a variety of soluble products 
that protect the tissue from both pathogens and inflammation. 
In the lungs, macrophages are critical mediators of both host defense 
and immune homeostasis.  Macrophages are found throughout the respiratory 
tree and are the major leukocyte subset found within the alveolar space.  A 
primary role of alveolar macrophages is to phagocytose and sequester inhaled 
antigens, thereby preventing the development of an adaptive immune 
response27.  TGF -dependent interactions with airway epithelial cells inhibit the 
inflammatory response of macrophages28.  However, in response to certain 
stimuli, including those provided by microorganisms or cytokines, alveolar 
macrophages will disengage with the airway epithelial cells and acquire a pro-
inflammatory phenotype in order to phagocytose and kill microorganisms and 
stimulate the innate immune response29, 30.  Neutrophils are the first responders 
to arrive after the pro-inflammatory innate immune response has been initiated.  
Neutrophils aid in host defense through the phagocytosis of microorganisms and 
particularly, through the release of microbicidal products.   
Antigens are acquired by LP-resident dendritic cells (DC) directly by 
sampling the lumen, or indirectly through the action of specialized Microfold (M) 
cells situated in the epithelium which transfer luminal antigens to DC in 
underlying lymphoid tissues including NALT and PP31, 32.  Interactions between 
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antigen-loaded DC and CD4+ T cells in the inductive sites determine the nature 
of the ensuing response.  In particular, the activation state of the DC affects the 
outcome of tolerance or inflammation33.  Evolutionarily conserved microbial 
products, termed pathogen-associated molecular patterns (PAMP), signal 
through PRR that are highly expressed by DC.  Signals received through PRR, 
including TLR, are synthesized in complex fashion that depends on the variety 
and duration of the stimulation34.  As an example, signaling through TLR9 on DC 
induced TReg activity in one study, and signaling through TLR4 or TLR9 on DC 
abolished TReg-mediated suppression in another
35, 36.  Therefore, interactions with 
microbial products can influence the propensity for DC to stimulate tolerance or 
inflammation. 
CD4+ T cells coordinate antigen-specific immune responses against 
inhaled or ingested antigens.  It is widely accepted that priming of CD4+ T cells 
requires contact with antigen presenting cells (APC), especially DC, that have 
acquired antigen, presented antigen in the context of MHCII, and expressed 
certain co-stimulatory receptors37, 38.  APC acquire antigen at the site of 
introduction and migrate to draining lymph nodes to prime naïve CD4+ T cells.  
Naïve CD4+ T cells undergo multiple rounds of division and progress through 
multiple stages of differentiation along the pathway to becoming effector CD4+ TH 
cells39.   
CD4+ TH cells differentiate into one of several distinct subsets that in turn 
mediate a distinct adaptive immune response “program”.  Each program has a 
genetic foundation in CD4+ TH cells.  Master regulation by a specific transcription 
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factor promotes the acquisition of a particular TH phenotype at the expense of the 
other phenotypes.  Tbet (Tbx21) promotes TH1 development, GATA3 promotes 
TH2 development, and it seems ROR T may similarly promote TH17 
development40-42.  Likewise, CD4+ TReg cells that inhibit CD4
+ TH activity to limit 
harmful inflammation are specified by the transcription factor Foxp343.  During 
CD4+ TH cell activation, the cytokine milieu present guides cellular differentiation 
along one of the particular pathways.  IL-12 along with IFN  promotes TH1 cell 
development, IL-4 promotes TH2 cell development, and the combination of TGF  
and IL-6 promotes TH17 development
44-47.  The presence of TGF  alone 
supports the differentiation of TReg cells.   
 Cytokine production represents a key effector function by which CD4+ TH 
cells coordinate adaptive immune responses48.  By producing a distinct set of 
cytokines, each CD4+ TH cell subset coordinates a distinctive adaptive immune 
response program that likely developed evolutionarily to counter a particular 
pathogenic threat.  TH1 cells produce IFN , along with IL-2 and TNF , and help 
protect against intracellular pathogens, but also mediate delayed-type-
hypersensitivity.  TH2 cells produce IL-4, IL-5, and IL-13 and promote a response 
to parasite infection, but also mediate allergic responses.  Recently identified 
TH17 cells produce IL-17.  TH17 cells promote damage to self-tissue in 
autoimmune disease, but it is not yet clear what their role is in host defense.  
Likewise, CD4+ TReg cells are recognized for the production of cytokines with anti-
inflammatory activity, including IL-10 and TGF , and are able to limit CD4+ TH 
responses.  The capacity of the immune system to prevent the development or 
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inhibit the activity of CD4+ TH cell responses against innocuous antigens is 
paramount to averting hypersensitivity disease. 
 Activated T and B cells travel through the lymphatics and eventually the 
thoracic duct where they enter the bloodstream and traffic to effector sites in the 
lamina propria (LP) and epithelium.  It is suggested that lymphocytes return to 
the tissue in which they were activated, and PP express mucosal vascular 
addressin cell-adhesion molecule 1 (MADCAM1) whereas NALT express 
peripheral-node addressin49.  However, lymphocyte migration to MLN relied on 
adhesion molecules that bind both mucosal and peripheral node addressins, 
indicating that MLN could serve an important role as a crossover point for cells 
activated in the GALT.  Activated B cells undergo immunoglobulin class switch to 
IgA in PP and NALT and are chemotactically attracted to the epithelium where 
they differentiate further into antibody-secreting plasma cells50, 51 52.  Likewise, 
“effector memory” CD4+ and CD8+ T cells and presumably, TReg also take up 
residence in the LP53, 54.  
 Antigens encountered at mucosal sites preferentially lead to tolerance 
induction.  As mentioned above, antigens delivered via oral, nasal, or airway 
routes can induce systemic unresponsiveness to the particular antigen.  Oral 
tolerance has been rigorously investigated for its therapeutic potential in the 
setting of autoimmune diseases, where prevention or amelioration was seen in 
mouse models of rheumatoid arthritis, multiple sclerosis and type I diabetes55-57.  
Oral tolerance can also inhibit the cardinal features of allergic airway disease 
(AAD) in the well-studied OVA model58.  In human adult volunteers, oral 
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tolerance was demonstrated after a prolonged feeding regimen with keyhole 
limpet hemocyanin resulted in T cell, but not B cell, systemic 
unresponsiveness59.   
 The mechanisms mediating oral tolerance depend on the dose of antigen 
administered60, 61.  High doses lead to anergy/deletion, but for this discussion the 
ability of low dose antigen to induce suppression is most interesting.  The results 
of depletion, reconstitution, and adoptive transfer studies convincingly 
demonstrate that tolerance in this setting is mediated by CD4+ TReg
62-65.  The 
mechanisms of TReg-mediated suppression are not entirely known, but it is clear 
that TReg require T cell receptor stimulation and that production of 
immunosuppressive cytokines, IL-10 and TGF , are critical mediators in vivo66.  
Thus, TReg require specific activation but can mediate nonspecific suppression in 
what is termed “bystander suppression.”  As mentioned previously, DC-T cell 
interactions control the immunological outcome, and expansion of the DC 
population with the in vivo administration of flt3 ligand can enhance the induction 
of oral tolerance67.   Similarly, repeated antigen exposure in the airways leads to 
the development of dominant tolerance mediated by CD4+ TReg
68.  Depletion and 
adoptive transfer studies of lung DC, indicate that these cells are crucial to 
tolerance induction at this mucosal site as well69, 70.  In humans, genetic 
deficiency in the FOXP3 gene that controls the transcriptional program for TReg 
commitment leads to a complex syndrome characterized by severe autoimmune 
and allergic manifestations71-73.  Moreover, defects in the ability of TReg from 
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allergic patients to inhibit allergen-specific TH2 responses support the functional 
role of these cells in maintaining tolerance74-76. 
   
Host Defense to Aspergillus fumigatus  
 Aspergillus fumigatus is a ubiquitous, airborne fungus that does not pose 
an infectious threat to immunocompetent individuals.  A. fumigatus is a 
eukaryotic organism with a complex life cycle.  Conidia are specialized bodies 
made expressly for the purpose of air-borne dissemination of the fungus.  
Conidia disseminate in a dormant, resting state, but they commence germination 
soon upon arrival in a warm, moist location, such as the lung77.  While pulmonary 
infection with A. fumigatus is a major concern in the treatment of 
immunosuppressed patients, the innate immune system effectively protects 
immunocompetent individuals.  
 The innate immune system efficiently clears the lungs of inhaled A. 
fumigatus conidia.  Macrophages and neutrophils cooperate to protect the host 
from A. fumigatus infection78.  Alveolar macrophages clear resting conidia without 
promoting inflammation79, 80.  Germination of conidia triggers a pro-inflammatory 
response in macrophages based on the recognition of fungal PAMP by host 
PRR79, 80.  The release of pro-inflammatory mediators results in the recruitment of 
neutrophils that assist in eliminating the inhaled fungus81, 82.  Pro-inflammatory 
cytokines including TNF  and IL-6 promote the innate host defense response83, 
84.  Innate inflammation may serve to promote an adaptive immune response. 
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Hypersensitivity to Aspergillus fumigatus 
 Due to the level of exposure and/or a genetic predisposition, inhaled A. 
fumigatus induces hypersensitivity responses in otherwise healthy individuals.  A. 
fumigatus is implicated in three lower respiratory tract hypersensitivity diseases:  
atopic asthma, allergic bronchopulmonary aspergillosis (ABPA), and 
hypersensitivity pneumonitis (HP).  CD4+ TH2 cells mediate atopic asthma and 
ABPA, and TH1 CD4
+ T cells participate in HP.  Interestingly, allergic asthma or 
HP may develop in different individuals exposed to A. fumigatus under very 
similar occupational circumstances, suggesting that the manifestation of either 
hypersensitivity disease may be determined primarily by the host response85, 86. 
 Allergic asthma is a lung hypersensitivity disease characterized by 
reversible obstruction of the airways.  An inappropriate inflammatory response to 
inhaled particles, the allergens, underlies the pathogenesis of allergic asthma. 
IgE, bound to the surface of mast cells, mediates the acute phase of the allergic 
response, and CD4+ TH2 cells mediate the late phase of the allergic response, 
including airway eosinophilia.  Inflammation organizes along the conducting 
airways in the peribronchial and peribronchiolar regions.  The inflammatory 
response leads to goblet cell metaplasia with mucous hypersecretion and 
remodeling of the peribronchial layers of smooth muscle and collagen.  The 
cumulative immunopathological effect is to render the airways hyperreactive to 
inhaled stimuli.  Upon re-exposure to the allergen, an “asthma attack” ensues.  
Sensitization to Aspergillus or other molds among populations of patients with 
severe asthma is 20-25%7-9, 87.  
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 Hypersensitivity pneumonitis is also termed ‘extrinsic allergic alveolitis.’  
In patients with HP, prolonged or repeated exposure to high levels of certain 
organic dusts induces an inappropriate inflammatory response.  It appears that 
particles of a certain size, those that they are able to reach the alveoli, may lead 
to HP.  The list of causative agents includes microorganisms that do not cause 
disease in healthy individuals, including A. fumigatus88-90.  Inflammation develops 
in the alveoli and in the interstitial space leading to thickening of the alveolar wall 
and eventually to interstitial fibrosis.  HP is associated with a CD4+ TH1 response, 
and other features of the underlying inflammation include an influx of neutrophils 
in terminal airways, a low CD4+/CD8+ T cell ratio, and the presence of 
precipitating IgG antibodies91.  Acute HP presents with fever, cough, and 
shortness of breath.  HP can be difficult to diagnose and, if untreated, can be 
severe.  The National Heart, Lung, and Blood Institute in collaboration with the 
Office of Rare Diseases of the National Institutes of Health recently called for an 
“improvement of animal models [for hypersensitivity pneumonitis] that are more 
relevant for human disease92.”  
 Allergic bronchopulmonary aspergillosis is a severe hypersensitivity 
disease induced by colonization of the airway by A. fumigatus93, 94.  Individuals 
with asthma or cystic fibrosis are most likely to develop ABPA, probably due to 
increased airway mucus.  Persistence of A. fumigatus in the airway leads to an 
intense CD4+ TH2 response, high levels of IgE and IgG antibodies, and 
accumulation of eosinophils and neutrophils in the airway.  In patients with 
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ABPA, the ongoing inflammation in the airway leads to severe asthma, 
bronchiectasis, and, potentially, fibrosis.   
 For patients with respiratory hypersensitivity diseases, the chronicity of 
the inflammation generally determines the severity of the morbidity and mortality.  
For those with asthma, chronic inflammation is associated with nonspecific 
bronchial hyperreactivity, and chronic inflammation promotes airway remodeling.  
Airway remodeling is associated with reversible airways obstruction95.  Bronchial 
hyperreactivity and reversible airways obstruction promote an “asthma attack”.  
The frequency, severity, and controllability of attacks combine to determine the 
morbidity and mortality of the disease.  Recent data suggests that chronic 
inflammation in asthma patients is associated with abnormal remodeling of 
bronchial arteries and narrowing of arterial lumens96.  Arterial remodeling is a 
component of the pathogenesis of pulmonary arterial hypertension (PAH), an 
idiopathic disease correlated with inflammation that can precipitate right sided-
heart failure and death97.  For those with HP, chronic inflammation can result in 
progressive, irreversible interstitial fibrosis, potentially leading to respiratory 
failure and death91. 
 
Investigations into the Allergic Response to A. fumigatus  
 Laboratory experiments demonstrate that exposure to A. fumigatus can 
result in multiple CD4+ TH subset responses.  The initial response to inhaled 
conidia includes the release of pro-inflammatory and TH1-promoting cytokines
81.  
After a single exposure to viable conidia, CD4+ TH1 cells develop
98, 99.  It is 
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currently unknown whether CD4+ TH1 cells induced by the inhalation of A. 
fumigatus conidia can mediate a hypersensitivity disease like HP with repeated 
exposure.  A. fumigatus hyphae or preparations of A. fumigatus antigens, 
containing hyphae and conidia present in the growing mycelium, are allergenic 
(i.e. TH2-promoting)
99-102.  The majority of allergens identified for A. fumigatus are 
derived from products expressed during germination9.  The ability of inhaled 
conidia to promote CD4+ TH2 cell development is less clear, but inhaled conidia 
stimulated a response from pre-formed CD4+ TH2 cells, present in mice 
previously sensitized to A. fumigatus antigens103.  Mice do not develop asthma 
per se, but they can develop an allergic airway disease (AAD) with many of the 
immunological features identified in atopic asthma. 
 In a series of experiments, Kurup and colleagues explored the 
development and immune regulation of the allergic response to A. fumigatus in 
mice.  Repeated intranasal exposure to A. fumigatus conidia, specifically 5 104 
conidia each day on days 0-15 and 25-30, resulted in peribronchial and 
perivascular inflammation with macrophages, lymphocytes, and eosinophils104.  
However, in a direct comparison, A .fumigatus antigens were more allergenic 
than conidia105.  The strength of the allergic response to inhaled A. fumigatus 
antigens was increased by several weeks of exposure, prior intraperitoneal 
sensitization, and attachment to inert particles100, 106, 107.  Sensitization and 
respiratory challenge with A. fumigatus antigens resulted in IL-5-dependent bone 
marrow, peripheral blood, and lung eosinophila108-112.  In this model, IgE 
production and the development of airway hyperreactivity were dependent on IL-
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4, but the absence of IL-4 had little effect on pulmonary inflammation and 
eosinophilia109, 113-115.  Neutralization experiments demonstrated that IFN  
normally limited the IgE and eosinophil responses to A. fumigatus exposure108.  
Interestingly, Kurup and colleagues reported fibromuscular thickening of 
bronchial vascular walls with chronic inflammation in this model of TH2 AAD to A. 
fumigatus. 
 Laviolette and colleagues developed a murine model of AAD that 
developed after exposure to A. fumigatus antigens three times a week for three 
weeks101.  Based on studies with the anti-inflammatory drug dexamethasone, 
data suggested that T cells promoted the allergic response to A. fumigatus 
characterized by lung eosinophil recruitment and increased IgE production116, 117.  
In this model, allergic inflammation was associated with increased production of 
IL-1, TNF , IL-4, IL-5, GM-CSF, and ICAM-1 in the lungs118-120. 
 Hogaboam et al. developed a model of chronic pulmonary inflammation 
involving the delivery of A. fumigatus conidia into the lungs of mice that were 
previously sensitized to A. fumigatus antigens via the intraperitoneal and 
intranasal routes103.  Thirty days after the delivery of conidia, sustained features 
of AAD included airway hyperreactivity, airway lymphocytes, TH2 cytokine levels, 
goblet cell metaplasia, and fibrosis.  The primary contribution of the TH2 immune 
response to the observed chronic allergic inflammation was demonstrated by 
disrupting IL-13 function and the signal transducer and activator of transcription 6 
(Stat6) pathway121-123.  The Hogaboam group used this model to extensively 
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characterize the role of various chemokine-signaling pathways in orchestrating 
the inflammatory response to A. fumigatus124-134. 
 Noverr et al. demonstrated that microbiota disruption promoted the 
development of an allergic airway response to A. fumigatus conidia or ovalbumin 
challenge135, 136.  In these studies, antibiotic-induced gastrointestinal (GI) 
microbiota disruption was accompanied by stable increases in GI enteric bacteria 
and C. albicans.  There was no evidence of microbial growth in the lungs or 
inflammation in the GI tract in this model.  The allergic parameters significantly 
elevated in the microbiota-disrupted mice included pulmonary eosinophilia, total 
serum IgE, lung leukocyte IL-5, IL-13, and IFN , and goblet cell metaplasia.  The 
response did not develop in IL-13-deficient mice or mice that had been depleted 
of CD4+ T cells.  In addition, vigorous allergic airway responses were generated 
in both C57BL/6 and Balb/c mice following microbiota disruption and antigen 






 Repeated respiratory exposure to viable A. fumigatus conidia will result in 




• To determine if repeated exposure to viable A. fumigatus conidia in previously 
unsensitized mice induces hypersensitivity. 
• To determine the phenotype and function of CD4+ T cells in the 
hypersensitivity response to A. fumigatus. 
• To determine the pulmonary pathophysiological consequences of a chronic 
hypersensitivity response to A. fumigatus.  
• To determine the immune mechanisms responsible for the hypersensitivity 






Figure 1-1.  CD4+ T cell subsets 
For each subset, this diagram depicts the cytokines responsible for CD4+ T cell 
differentiation, the transcription factors that regulate the CD4+ T cell phenotype, 
and the cytokines that mediate the CD4+ T cell effector functions.  This diagram 
also depicts the type(s) of adaptive immune response(s) coordinated by each 




Figure 1-2.  Innate and adaptive immune response to Aspergillus fumigatus  
This diagram depicts the leukocytes that are involved in the response to various 
biological forms of A. fumigatus after inhalation.  Macrophages (M ) kill resting 
and germinating conidia and neutrophils (PMN) kill hyphae.  Resting conidia do 
not induce a pro-inflammatory response from M , but germinating conidia do.  
The innate inflammatory response mediated by M  includes the production of 
TNF  and the recruitment of PMN.  Viable conidia are reported to prime CD4+ 
TH1 and TH17 cells.  Hyphae and fungal extract, composed of all forms but 
primarily hyphae, are reported to prime CD4+ TH2 cells.  CD4
+ TReg cells respond 
to viable conidia and hyphae and inhibit CD4+ TH cell responses.  Nonviable, 
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Materials and Methods 
 
 
Mice.  IL-4-/- (B6.129P2-Il4tm1Cgn/J), IL-10-/- (B6.129P2-Il10tm1Cgn/J), IFN -/- 
(B6.129S7-Ifngtm1Ts/J), and wild-type (C57BL/6J) mice were obtained from the 
Jackson Laboratories (Bar Harbor, ME).  IL-5-/- mice on a C57BL/6 background 
were obtained from a breeding colony maintained at the University of Michigan.  
Mice were housed under pathogen-free conditions in enclosed filter-topped 
cages. Clean food and water were given ad libitum. The mice were handled and 
maintained using microisolator techniques, with daily veterinarian monitoring.  All 
studies involving mice were approved by the University Committee on Use and 
Care of Animals at the University of Michigan 
 
Aspergillus fumigatus.  Strain ATCC 13073 was grown on Sabouraud dextrose 
agar (Difco) for 14 days.  Conidia were harvested by washing plates with sterile 
phosphate-buffered saline (pH 7.4) with 0.1% Tween 80 (PBS-Tween), followed 
by filtration of the suspension through two layers of sterile gauze to remove 
hyphae.  Conidia were washed in PBS-Tween, counted with a hemocytometer, 
diluted to 108 spores/ml in sterile PBS-Tween, and stored at 4°C for up to 4 
months.  
 
Respiratory Exposure Protocol.  For each exposure, 2 106 conidia/mouse 
were administered to the nostrils of mice in a volume of 20μl.  Repeat intranasal 
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exposures were administered every 7 days.  Prior to intranasal inoculation, mice 
were anesthetized by intraperitoneal injection of a ketamine-xylazine solution (2.5 
mg of ketamine (Fort Dodge Animal Health, Fort Dodge, IA)/mouse plus 0.1 g of 
xylazine (Lloyd Laboratories, Shenandoah, IA)/mouse). 
 
Lung Histology.  Lungs were fixed by inflation with 10% neutral buffered 
formalin. After paraffin embedding, 5- m sections were cut and stained with 
hematoxylin and eosin, periodic acid-Schiff (to detect mucus), Masson's 
trichrome (to detect collagen), Verhoeff’s-van Gieson’s (to detect elastin), and 
Gomori’s methenamine-silver (to dectect fungi). 
 
Bronchoalveolar Lavage for Cell and Solute Recovery.  Airway contents were 
recovered by instillation and retrieval of 1ml of sterile PBS through a tracheotomy 
tube.  The first lavage was centrifuged and the cell-free fluid was immediately 
frozen down at -20°C.  Cells collected with three total lavages were pooled.  After 
erythrocyte lysis using NH4Cl buffer (0.83% NH4Cl,
 0.1% KHCO3, 0.037% Na2 
EDTA, pH 7.4), cells were washed, resuspended in complete medium (RPMI 
1640, 10% fetal calf serum, 2 mmol/liter L-glutamine, 50 mol/liter 2-
mercaptoethanol, 100 U/ml penicillin, 100 g/ml streptomycin sulfate), and 




Flow Cytometry for Cell Surface Molecules.  Cells were washed and 
resuspended at a concentration of 107 cells/ml in FA buffer (Difco) + 0.1% NaN3, 
Fc receptors were blocked by the addition of unlabeled anti-CD16/32 (Fc block; 
BD Pharmingen, San Diego, CA).  After Fc receptor blocking, 0.5-1 106 cells 
were stained in a final volume of 100 l in 12 x 75-mm2 polystyrene tubes 
(Becton Dickinson, Franklin Lakes, NJ) for 30 minutes at 4°C.  All antibodies 
used for flow cytometry were obtained from BD Pharmingen and used per the 
manufacturer’s instructions.  Cells were washed twice with FA buffer, 
resuspended in 100 l, and an equal volume of 4% formalin was added to fix the 
cells.  A minimum of 20,000 events were acquired on a FACScaliber flow 
cytometer (BD Pharmingen) using Cell-Quest software (BD Pharmingen).  
Acquired data was analyzed with FlowJo software (Tree Star, Standford, CA). 
 
Flow Cytometric Leukocyte Differential Analysis.  Cells of the main leukocyte 
subsets, macrophages, neutrophils, lymphocytes, and eosinophils, were 
distinguished by virtue of unique combinations of FSC and SSC profiles and 
CD11c and Gr1 surface expression, as described in detail in Appendix 1.  During 
the development of the method BAL leukocytes were enriched via fluorescence-
activated cell sorting (FACS).  FACS analysis was performed on a FACSVantage 
SE Cell Sorter (BD Immunocytometry systems, San Jose, CA). 
 
Blood Collection and Serum Separation.  Blood was collected from the tail 
vein of live mice or by retro-orbital vein bleed at the time of harvest.  Serum was 
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collected after centrifugation for 1min at 6000rpm in Microtainer tubes (BD 
Pharmingen). 
 
Enzyme-Linked Immunosorbent Assay.  Cytokines in BALF and IgE in serum 
were measured by sandwich ELISA using the manufacturer’s instructions 
supplied with the specific kits (BD Pharmingen and R&D Systems).   
 
Airway Resistance.  Bronchial hyperresponsiveness was measured in a 
BuxcoTM plethysmograph (Buxco, Troy, NY, U.S.A.) as previously described1.  
Each mouse was anesthetized with sodium pentobarbital (Butler Co., Columbus 
OH; 0.4mg/g of body weight), intubated via the trachea, and ventilated with a 
Harvard pump ventilator (Harvard Apparatus, Reno, NV).  Ventilation parameters 
were set as follows:  tidal volume = 0.25ml, respirations = 120/min, and positive 
end-expiratory pressure = 3 cm H2O.  Transpulmonary pressure (i.e. tracheal 
pressure – mouse chamber pressure) and inspiratory volume or flow were 
continuously monitored by computer.  Using Buxco software, airway resistance 
was calculated by the division of transpulmonary pressure by the change in 
inspiratory volume and continuously displayed online.  Values for airway 
resistance on the Buxco apparatus were recorded at baseline and after direct 
airway exposure to 1 mg and 1.6 mg of nebulized methacholine.  These 
methacholine doses were chosen based on the results of previous experiments 




Spleen and Lymph Node Cell Preparation.  Spleens and lung-draining lymph 
nodes (LDLN) were excised and cells dispersed with the plunger of a 3-ml 
syringe.  After erythrocytes were lysed with NH4Cl buffer, cells were washed and 
resuspended in complete media. 
 
Flow Cytometry for Intracellular Molecules.  Prior to intracellular cytokine 
staining, cells were stimulated in vitro for 5 hours with PMA (50ng/ml) and 
ionomycin (1μg/ml) in the presence of brefeldin A (BD Pharmingen) to promote 
the intracellular accumulation of cytokines.  After stimulation, cells were washed 
twice prior to surface molecule staining.  After surface molecule staining, 
intracellular molecules were stained using the BD Cytofix/Cytoperm kit according 
to the manufacturer’s instructions (BD Pharmingen). 
 
CD4+ Cell Depletion.  Mice were treated intraperitoneal injections with 300 g of 
anti-CD4 monoclonal antibody (MAb) GK1.5 on the day prior to the first exposure 
to conidia and boosted with 100 g of MAb every 7 days.  Antibody was prepared 
from ascites by dilution in PBS and filtering through a 0.45- m syringe filter.  The 
efficiency of T-cell depletion was assessed by flow cytometric analysis using anti-
CD4 Ab RM 4-4, which binds to a region of CD4 distinct from GK1.5.  Depletion 
was >99% for CD4+ T cells in the lungs as well as spleen.  Anti-CD4 antibody 
(GK1.5) prevents the development of an anti-rat Ig response because an anti-rat 
Ig response requires CD4+ T-cell help. Thus, PBS diluent was used for control 
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mice instead of isotype-matched rat Ig that would lead to a mouse anti-rat Ig 
response, potentially resulting in Ab-antigen complexes and immune deviation or 
inflammation. 
 
Lung Digest for Whole Lung Leukocyte Enrichment.  Lungs from each mouse 
were excised, washed in PBS, minced, and digested enzymatically for 30 
minutes in 15 ml/lung of digestion buffer (RPMI, 5% fetal calf serum, 1 mg/ml 
collagenase (Boehringer Mannheim Biochemical, Chicago, IL), and 30 g/ml 
DNase (Sigma Chemical Co., St. Louis, MO)). After erythrocyte lysis using NH4Cl 
buffer, cells were washed, resuspended in complete media, and centrifuged for 
30 minutes at 2000 x g in presence of 20% Percoll (Sigma) to separate 
leukocytes from cell debris and epithelial cells. Total lung leukocyte numbers 
were assessed in the presence of trypan blue using a hemocytometer. 
 
CD4+ T Cell Enrichment.  CD4+ T cells were enriched from splenocyte 
populations and from combined lung and LDLN populations via magnetic-
activated cell sorting (MACS).  For MACS, cell suspensions were stained with 
CD4 (L3T4) Microbeads (Miltenyi Biotec, Auburn, CA) and enriched via positive 
selection on a MidiMACS separator (Miltenyi Biotec).  Enriched populations were 
>90% pure as assessed by flow cytometry. 
 
CFSE Staining.  After enrichment, and before adoptive transfer, CD4+ T cells 
were labeled with the Vybrant CFDA SE (CFSE) Cell Tracer Kit (Molecular 
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Probes, Eugene, OR) according to the manufacturer’s instructions.  CFSE is 
fluorescent dye that is retained within cells and divided between daughter cells 
with each division. 
 
Adoptive Transfer.  Enriched, CFSE-labeled CD4+ T cells were suspended in 
PBS at 0.8-1 107/ml and 1ml of cell suspension was adoptively transferred to 
naïve recipient mice via lateral tail vein injection. 
 
Immunohistochemistry.  Immunohistochemistry was performed as previously 
described2.  Lungs were inflated and fixed in 10% buffered formalin overnight, 
embedded in paraffin, and sectioned. Following de-paraffinization and 
rehydration, sections were blocked and then stained with or anti- -smooth 
muscle actin (SMA) antibody (clone 1A4, DAKO, Carpinteria, CA). Color 
development for -SMA staining was achieved with DAB (Vector Labs, 
Burlingame, CA). Sections were then counterstained with hematoxylin and 
mounted. 
 
Morphological Leukocyte Differential Analysis.  Macrophages, neutrophils, 
lymphocytes, and eosinophils were visually counted by standard morphological 
criteria in Wright-Giemsa-stained samples of lung cell suspensions cytospun onto 
glass slides (Shandon Cytospin, Pittsburgh, PA).  For Wright-Giemsa staining, 
the slides were fixed for 2 min with a one-step, methanol-based Wright-Giemsa 
stain (Harleco; EM Diagnostics, Gibbstown, NJ) followed by steps 2 and 3 of the 
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Diff-Quik whole-blood stain kit (Diff-Quik, Baxter Scientific, Miami, FL).  A total of 
200 to 300 cells were counted from randomly chosen high-power microscope 
fields for each sample. 
   
Right Ventricular Systolic Pressure.  Mice were anesthetized by 
intraperitoneal injections with ketamine and xylazine.  A 19-gauge metal 
tracheostomy tube, fitted with an adaptor to attach to a mechanical ventilator, 
was inserted into the trachea and secured with a nylon suture.  Mice were placed 
on a mechanical ventilator (settings: respiratory rate 150 breaths/minute, volume 
limits engaged (max 2.0ml), and minimum 30% of the breath cycle for exhalation) 
as part of the Pulmonary Maneuvers System (Buxco Electronics).  A midline 
thoracotomy was performed and the chest wall was retracted exposing the heart.  
A 26 gauge needle attached to pressure tubing connected to a Cobe pressure 
transducer (Cobe Cardiovascular, Arvada, CO) was inserted into the right 
ventricle.  After RV pressure was recorded, a blood sample was obtained by 
ventricular puncture with a heparinized syringe.  The mouse was then euthanized 
for organ harvest.  The RVSP and heart rate were obtained by analyzing tracings 
using the Left Ventricular Pressure Analyzer as part of Biosystem XA software 
(Buxco, Electronics).  RVSP for six consecutive beats were averaged to obtain 
the mean RVSP for each mouse.  RVSP measurements were excluded if the 
heart rate dropped below 300 beats per minute based on published 
investigations into cardiac function3.  The total time of mechanical ventilation 
required for these measurements was less than 5 minutes. 
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Morphometric Analysis of Pulmonary Arteries.  Excised lungs were inflated 
via the trachea with 1 cc of 10% buffered formalin. The trachea was ligated and 
the lungs were immersed in 10% buffered formalin for 24 hours.  The left lung 
from each mouse was removed, imbedded in alginate, and sectioned into 3mm 
slices along the long axis.  A coin flip determined whether odd or even sections 
were chosen for analysis.  After embedding the chosen slices in paraffin, five-
micron sections were cut, fixed to glass slides, and stained with hematoxylin and 
eosin.  Morphometry was performed using an Olympus BX40 microscope fitted 
with a DP71 digital camera (Olympus, Melville, NY) and a XYZ microscope stage 
(Prior Scientific, Rockland, MA) controlled by a Dell computer running Visopharm 
v 2.14 software (Visopharm, Denmark).  Slides were coded and analyzed by the 
reader in a blinded fashion.  Using a 4x low power objective, the entire area of 
lung from each tissue section was outlined and included in the sampling area.  
Under 40x magnification, a computer assisted sampling protocol chose a random 
starting field from the selected area and subsequent fields were determined by 
using a fixed step in the x and y position.  Thus, a random sampling of the entire 
tissue section was examined allowing for objective measurements.  All muscular 
pulmonary arteries appearing in the selected fields were assessed.  For each 
artery, diameter (in both the long and short axis), total area, and luminal area 
were measured and recorded.  A value of % lumen was obtained by dividing the 
luminal area by the total area x100%.  Vessels were excluded from analysis if the 
length/width measurements were >2.5 to exclude tangentially sliced arteries.  
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Vessels were excluded from analysis if the total area was >20,000μm2 to exclude 
large pulmonary arteries.  Data for each artery measured was pooled within each 
experimental group from 2-4 separate experiments.  
 
Right Ventricular Mass.  The great vessels and atria were removed from the 
ventricles and septum for each mouse.  The right ventricular (RV) free wall was 
dissected away from the septum (S) and attached left ventricle (LV).  The 
masses of the RV free wall and the S+LV were measured.  The right ventricle 
mass was calculated by RV/(RV+(S+LV)). 
 
Blood Hemoglobin.  A blood sample was obtained by ventricular puncture with 
a heparinized syringe, placed on ice, and hemoglobin content was determined 
within 30 min at the hematology lab at the Veterans’ Affairs Hospital (Ann Arbor, 
MI). 
 
Statistical Analyses.  All values are reported as mean ± standard error of the 
mean unless otherwise noted.  Mean values were pooled from 2-4 independent 
experiments unless otherwise noted.  Differences between two groups were 
evaluated with a two-tailed Student’s t test, and all differences between three or 
more groups were evaluated with a one-way ANOVA with Bonferroni’s multiple 
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Hypersensitivity Response to Aspergillus fumigatus:  Development of 





 Upon re-exposure, an unnecessary and over-exuberant adaptive immune 
response to Aspergillus fumigatus can result in the development of 
hypersensitivity diseases, including allergic asthma and hypersensitivity 
pneumonitis (HP)1.  Hypersensitivity responses to A. fumigatus likely result from 
the inhalation of conidia, because conidia are specialized structures made 
specifically for the air-borne dissemination of the fungus2.  Atopic asthma is 
mediated by a TH2 immune response, and HP is characterized by a TH1 immune 
response.  As is the case with humans, inhalation of A. fumigatus by mice 
reportedly can lead to TH1 and/or TH2 immune responses
3, 4.  However, the 
response to repeated inhalation of viable A. fumigatus conidia has not been well 
studied.  A common weakness of murine studies of hypersensitivity disease is 
the necessity for systemic immunization with antigen to prime the hypersensitivity 
response. 
 
Hypothesis   
 Pulmonary hypersensitivity disease will result from repeated inhalation of 




1. To determine the strength and character of the local immune response 
after each of multiple, weekly inhalations of viable A. fumigatus conidia. 
2. To determine the extent of histopathological alterations in the lung 
following repeated inhalation of conidia. 
3. To determine the extent of pathophysiological alterations in pulmonary 
function following repeated inhalation of conidia. 
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RESULTS 
 To determine if repeated exposure to viable conidia led to the 
development of a hypersensitivity response to Aspergillus fumigatus, a kinetic 
study was performed.  Based on the results of a preliminary examination (see 
Appendix 2, Figure A2-1), a “minimum inflammatory dose” of 2 106 viable conidia 
was instilled intranasally into C57BL/6 mice every 7 days, and mice were 
evaluated 24 hours after each exposure. The study was focused on the 
evaluation of characteristic features of the clinical hypersensitivity diseases, 
atopic asthma and HP, that may be caused by A. fumigatus. 
 To demonstrate that the fungus did not escape innate immune clearance 
in the lung, histological samples of lung tissue were stained with gomori 
methenamine silver (GMS) 24 hours after each exposure (Figure 3-1).  GMS 
stains fungal material black.  Few, sporadic conidia were identified in each lung 
sample, and most were found inside phagocytes.  Rare conidial or hyphal 
germinations were observed, but not overt growth of the fungus as seen in the 
anti-Gr1-treated neutropenic mice.  Mice examined after three exposures did not 
have more GMS-stained fungi than mice harvested after one exposure, 
suggesting that A. fumigatus growth and persistence were prevented.   
 Histological sections of lung tissue were stained with H&E to examine 
cellular inflammation (Figure 3-2).  Cells accumulated adjacent to the airways 
distally to the level of the terminal bronchioles.  Inflammation was considerably 
more pronounced after three exposures than after one.  The alveoli were 
relatively clear of inflammatory infiltrate.  This pattern of inflammation is more 
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consistent with atopic asthma, an allergic airway disease (AAD), than with HP, an 
alveolitis. 
In order to quantify the cellular infiltrate, cells were recovered from the 
airway by bronchoalveolar lavage (BAL) and counted under a light microscope 
(Figure 3-3).  A single exposure to conidia induced a slight increase in the total 
number of cells present 24h later.  A similar magnitude of cells was measured 
after the second exposure.  However, the total number of cells recovered from 
the airway increased significantly, by several-fold, after the third exposure, 15 
days after the initial exposure. 
 In order to characterize the cellular infiltrate, leukocyte differential 
analyses were performed on cells recovered from the airway using flow 
cytometry according to the method described in Appendix 1 (Figure 3-4).  The 
total number of macrophages was relatively constant throughout the period of 
exposure and similar in number to unexposed mice. Neutrophils are a critical 
component of the innate host defense to A. fumigatus.  Neutrophils constituted 
the majority of the cells recruited after a single exposure, and similar numbers of 
neutrophils were present after each subsequent exposure.  Eosinophils 
predominated in the airway after three exposures, coinciding with the surge in 
total cell number.  Airway eosinophilia is a cardinal feature of asthma.  
Lymphocytes increased significantly after three exposures, as well.  The 
significant increase in lymphocytes and eosinophils coupled with an absence of 
fungal accumulation was evidence of a hypersensitivity response manifesting as 
an AAD.   
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 To analyze the quality and intensity of the response to inhaled conidia, 
cytokines were measured in the bronchoalveolar lavage fluid (BALF), collected 
24h after exposure, by ELISA (Figure 3-5).  A single exposure to conidia led to 
an increase in TNF .  As TNF  is a component of the innate inflammatory 
response, this observation was consistent with the early recruitment of 
neutrophils to the airway.  The level of IL-5, a prototypical TH2 cytokine, 
increased significantly after three challenges.  IL-5 is critical for the recruitment of 
eosinophils, so the detection of IL-5 was consistent with the influx of eosinophils 
previously observed.  Not surprisingly, the level of detectable IL-4 followed the  
trend for IL-5, but the low amount of IL-4 was just above the level of detection 
(see Appendix 2, Figure A2-2).  The level of IFN  was low-to-undetectable after 
each exposure (see Appendix 2, Figure A2-2).  The early detection of TNF  was 
consistent with a role in the innate immune response.  The production of IL-5 
after several exposures was further evidence of a mounting TH2 response. 
 The secretion of IgE was measured serially in mice after each exposure to 
A. fumigatus (Figure 3-6).  A small sample of blood was collected from the tail 
vein, and the total IgE level in the serum was measured by ELISA.  After four 
exposures, mice that inhaled conidia had significantly higher levels of total IgE in 
the serum than mice that inhaled vehicle only.  TH2 CD4
+ T cells instruct B cells 
to produce IgE, and increased IgE is a hallmark of an allergic reaction.  
Increased IgE is not associated with HP. 
 Lung histopathology was examined with periodic acid-Schiff (PAS) stain to 
identify mucus (Figure 3-7).  Mucus hyperproduction was apparent in the upper 
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airways of mice exposed to conidia multiple times, but not in naïve mice.  Goblet 
cell metaplasia and mucus hypersecretion contribute to airway obstruction in 
asthma5.   
 While mice do not develop a breathing disorder similar to asthma, 
increased airway resistance is often demonstrated by methacholine challenge6.  
In spite of the presence of multiple features of AAD, mice repeatedly exposed to 
conidia did not exhibit a significant increase in airway resistance compared to 





Figure 3-1.  Aspergillus fumigatus does not escape host protection in the 
lungs of mice after repeated, weekly inhalation of viable conidia. 
Histological sections of lung tissue were stained with Gomori Methenamine Silver 
in order to detect fungal material, which is stained black.  Representative 
photomicrographs are shown.  An unexposed lung sample is included as a 
negative control (i).  A lung sample from a mouse treated with anti-Gr1 to deplete 
neutrophils is included as a positive control for A. fumigatus infection (ii).  
Additional lung samples demonstrate the fungal burden that was present 24h 
after one exposure (iii) and 24h after the third weekly exposure (iv).  Rare 
germlings were found in immunocompetent mice (iii – inset).  Arrows point to 
phagocytosed conidia, and asterisks identify hyphal germinations.  Black bars 




Figure 3-2.  Cellular inflammation organizes along the airways distally to 
the bronchioles. 
Histological sections of lung tissues were stained with H&E.  Representative 
photomicrographs include terminal bronchioles.  Images depict the extent of 
cellular inflammation present in an untreated sample (0), 24h after the first 
exposure (1), and 24h after the second and third weekly exposures (2 and 3, 




Figure 3-3.  A significant increase in airway cellular inflammation occurs 
after several, weekly exposures.  
Cells were recovered from the airway by bronchoalveolar lavage and 
enumerated under a light microscope with a hemacytometer.  These data were 
collected from three independent experiments for each group, containing three or 
mice per group per experiment.  The mean value for each group in each 
experiment was compiled.  The graph illustrates the mean (+ SEM) number of 
total cells present in the airways 24h after 0, 1, 2 or 3 weekly exposures.  *p < 








Figure 3-4.  The innate immune system responds to a single exposure and the 
adaptive immune system responds after several exposures.   
Cells were recovered from the airway, and leukocyte differentials were performed by 
flow cytometry according to the method described in Appendix 1.  A) Representative 
density plots show the expression of CD11c and Gr1 for the total cell populations 
recovered.  The central densities of individual leukocyte subpopulations are labeled 
(M=macrophage, N=neutrophil, L=lymphocyte, and E=eosinophil).  B) The numbers of 
recovered cells belonging to each leukocyte subset are presented on the bar graphs 
(see y-axis labels).  Mean (+SEM) of cell numbers compiled from the means of two 
independent experiments are shown. * p < 0.05 for 3 exposures compared to 0 or 1 





Figure 3-5.  Peak levels of innate inflammatory and TH2 cytokines coincide 
with the pattern of leukocyte recruitment.  
Cytokines present in the cell-free bronchoalveolar lavage fluid were quantified by 
ELISA.  The bar graphs depict the mean (+SEM) for individual samples collected 
from two independent experiments (n=3 per group per experiment; “0 exposures” 
group included in one of the two experiments but consistent with additional 
independent experiments).  The limit of detection for each assay is indicated with 
a horizontal line.  *p < 0.01 compared to 0 exposures and p < 0.05 compared to 2 




Figure 3-6.  Increased serum IgE is a component of the allergic response to 
repeated exposure. 
Mice were exposed to vehicle control or A. fumigatus conidia (Af) on a weekly 
basis.  Blood was collected serially from the tail vein of each mouse 72h after 
every exposure.  Total IgE levels in the serum were quantified by ELISA.  *p < 




Figure 3-7.  Development of goblet cell metaplasia and mucous 
hypersection is evident in the upper airways. 
Histological sections of lung tissue were stained with PAS in order to detect 
mucous, which is stained purple.  Representative photomicrographs include 
conducting airways from mice exposed to A. fumigatus 0, 1, 2 or 3 times at 




Figure 3-8.  Airway hyperresponsiveness does not develop despite the co-
existence of many features of allergic airway disease. 
As described in the material and methods, bronchial resistance was measured in 
a whole body plethysmograph 24h after a given number of exposures (see bar 
graph legend).  Briefly, resistance values were calculated in real-time for 
anesthetized and ventilated mice at baseline and after direct respiratory 
challenge with 20μl of a nebulized methacholine solution (see x-axis labels) at 
doses previously determined to elicit significant responses in hyperreactive mice.  
Mean (+SEM) for five mice per group are shown.  An independent experiment, 
including groups exposed 0 and 4 times, produced similar results. 
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DISCUSSION 
 The data presented in this chapter demonstrated that a hypersensitivity 
response to A. fumigatus developed after repeated inhalation of viable conidia in 
the absence of fungal growth or persistence.  Many features of the 
hypersensitivity response were similar to prototypical features of atopic asthma, 
an AAD.  These features included the presence of peribronchial and 
peribronchiolar cellular infiltrate, significant airway eosinophilia, the presence of 
TH2 cytokines in the airway, the increased production of IgE, and goblet cell 
metaplasia with mucus hypersecretion7.  In spite of the characteristic AAD, 
hypersensitive mice did not exhibit increased airway resistance after inhalation of 
conidia.  
 The growth of A. fumigatus was prevented in the lungs of C57BL/6 mice 
throughout the study.  Of the few, sporadic conidia detected in silver-stained lung 
sections, the majority appeared to be small, resting conidia residing inside 
macrophage cells.  However, rare germinating conidia or hyphae were also 
detected.  The germination of resting conidia is a critical event in the 
development of innate and adaptive immune responses to A. fumigatus.  During 
germination, fungal molecules, such as -glucans, are exposed and recognized 
by pattern recognition receptors of the innate immune system8, 9.  In response to 
germinating, but not resting conidia, macrophages produced pro-inflammatory 
mediators including TNF 8, 9.  The inhalation of viable, but not nonviable, resting 
conidia also promoted a TH1 response
4, 10.  It is suspected that the majority of A. 
fumigatus allergens, that are the target of a TH2 response, are likely expressed 
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by the organism during germination11.  Finally, the intratracheal delivery of A. 
fumigatus hyphae resulted in the priming of TH2 cells in the draining lymph 
nodes12.  Based on these data, we suspect that germination of the viable conidia 
after inhalation resulted in the initiation of the immune response that resulted in 
hypersensitivity to the fungus. 
 After a single exposure to conidia, an innate immune response was 
evidenced by increased TNF  secretion and neutrophil recruitment.  Growth of 
the inhaled conidia was prevented throughout the period of study, and the 
amount of fungal material detected by histological examination was similar 24 
hours after the first and the third exposures.  It is well known that the innate 
immune system of immunocompetent mice readily clears the lungs of inhaled 
conidia of A. fumigatus13.  Both TNF  and neutrophils were previously reported 
to participate in the innate host defense response to inhaled A. fumigatus 
conidia14, 15.  The ability of the innate host defense response to prevent the 
growth of inhaled conidia suggested that the robust allergic airway response that 
developed with repeated exposure was likely unnecessary and potentially 
harmful to the host. 
 The hypersensitivity response documented in the present study contained 
many prototypical features of a TH2 AAD.  The evidence of an AAD included a 
peribronchial-peribronchiolar pattern of inflammation, significant airway 
eosinophilia, increased BALF IL-5, elevated serum IgE levels, and airway mucus 
hyperproduction.  On the other hand, features of HP that were not detected in 
this study included alveolitis, a granulocytic response primarily consisting of 
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neutrophils, and a low CD4+/CD8+ T cell ratio (see Appendix 2, Figure A2-3).  It is 
suspected that CD4+ TH1 cells contribute to the hypersensitive inflammatory 
response in HP16.  A single inhalation of A. fumigatus conidia resulted in the 
priming of CD4+ TH1 cells
4, 12.  In the present study, the presence of CD4+ TH1 
cells was not determined directly, but indirect evidence of a robust CD4+ TH1 
response was absent.  For instance, robust CD8+ T cell recruitment, present in 
TH1-associated HP, was not observed.  Instead, indirect evidence of a 
substantial CD4+ TH2 response was apparent based on the development of many 
features of AAD.  
In the present study, C57BL/6 mice did not develop a significant increase 
in airway resistance after repeated inhalation of A. fumigatus conidia.  In several 
studies comparing airway hyperresponsiveness (AHR) among different strains of 
mice, C57BL/6 mice were characterized as a low-responder strain17-19.  Also, 
systemic allergen priming with adjuvant is employed commonly in laboratory 
mice to promote increased AHR after subsequent allergen exposure.  Based on 
the extent of the AAD induced in this study, it is possible that similar treatment of 
a different laboratory strain of mice with a stronger genetic predisposition would 
result in significant AHR.  Alternately, initial systemic allergen priming with 
adjuvant may enhance the AHR phenotype.  However, these data demonstrated 
that viable A. fumigatus conidia, a natural aeroallergen in its native form, induced 
a robust hypersensitivity response upon re-exposure in the airway in the absence 
of systemic priming. 
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 The generation of an experimental AAD by repeated inhalation of viable A. 
fumigatus conidia represented a unique addition to the published literature, but at 
least three other groups have reported A. fumigatus-induced AAD models20-22.  In 
the first model, characteristic AAD resulted from repeated intraperitoneal 
sensitization with A. fumigatus antigen extract admixed with alum followed by 
repeated intranasal exposure to A. fumigatus antigen21.  In the second model, 
significant AAD developed at week three after repeated inhalation of A. fumigatus 
antigen extract three times a week22.  In the third model, a robust AAD resulted 
after systemic sensitization to A. fumigatus antigen extract with adjuvant, 
followed by intranasal exposure to extract and intratracheal delivery of viable 
conidia20.  We elected to repeatedly expose mice to viable A. fumigatus conidia 
via the intranasal route, because we aimed to recapitulate the pathogenesis of 
clinical hypersensitivity responses that develop as a consequence of the 
exposure to allergens at the respiratory mucosa.   
 In conclusion, repeated inhalation of viable A. fumigatus conidia resulted 
in the development of a hypersensitivity response manifesting as an AAD.  
Currently, there is a paucity of animal models for AAD that result from a natural 
route of exposure to a natural aeroallergen in its native form6.  Our model affords 
the opportunity for further investigation into the immunopathogenesis of 
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Hypersensitivity Response to Aspergillus fumigatus:  Phenotype and 




Rationale   
 CD4+ TH2 cells are widely recognized as central mediators to the 
pathogenesis of allergic airway disease (AAD)1, 2, but the phenotype and function 
of CD4+ T cells in the hypersensitivity response to viable Aspergillus fumigatus 
conidia requires further investigation.  The role of TH1 cells in AAD is somewhat 
controversial, because conflicting reports suggested that TH1 responses may 
abrogate or augment TH2-mediated AAD
3.  Several studies reported that 
inhalation of viable A. fumigatus conidia resulted in an innate pro-inflammatory 
response and a CD4+ TH1 cell response
4-7.  Previous reports indicated that the 
induction of a TH2 response to A. fumigatus required the use of purified antigens 
with or without systemic priming8-11.  When exposed to chitin, a fungal product, or 
proteases purified from Aspergillus species, recent reports demonstrated that 
innate immune cells were capable of mediating components of the allergic 
response, including the recruitment of eosinophils, in the absence of an adaptive 
immune system12, 13.   
 
Hypothesis 
 CD4+ T cells mediate the hypersensitivity response to inhaled viable A. 
fumigatus conidia upon re-exposure. 
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Objectives   
1. To determine the association of CD4+ TH cells with the development of the 
hypersensitivity response to A. fumigatus. 
2. To determine the necessity for CD4+ T cell involvement in the 
development of the hypersensitivity response to A. fumigatus. 
3. To determine the sufficiency of CD4+ T cells to mediate the development 




 To determine if CD4+ T cells mediated the hypersensitivity response to A. 
fumigatus conidia the phenotype and functional role of CD4+ T cells was 
examined with a variety of methods.  The kinetics of CD4+ T cell accumulation in 
the airway after repeated inhalation of conidia was determined by flow cytometric 
analysis of cells recovered by bronchoalveolar lavage (BAL) (Figure 4-1).  Very 
few CD4+ T cells were detected in naïve mice or after one exposure, and there 
was a modest increase in CD4+ T cells after the second exposure.  A substantial, 
significant accumulation of CD4+ T cells was detected after the third exposure, 
coinciding with the onset of the AAD. 
 CD4+ T cell activation was examined by flow cytometric analysis of cells 
harvested from the spleen, lung-draining lymph node (LDLN), and BAL (Figure 4-
2).  Spleen samples from naïve mice were included as a control population of 
naïve CD4+ T cells.  There was very little difference in surface activation marker 
expression among CD4+ lymphocyte populations isolated from the spleen of 
naïve mice and the spleen and LDLN of mice exposed to conidia four times.  In 
contrast, the CD4+ lymphocytes recovered from the airway (BAL) exhibited an 
activated phenotype.  BAL CD4+ T cells were uniformly CD44-positive while 
greater than 75% of CD4+ T cells from the other tissues were CD44-negative.  
The populations expressing CD69 and CD69 plus CD25 were more than doubled 
in frequency in the BAL sample compared to those recovered from the secondary 
lymphoid tissues.   
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CD25 is also expressed by a majority of natural T regulatory cells (TReg) 
that co-express the transcription factor Foxp314.  Intracellular staining for Foxp3 
was performed to distinguish CD4+CD25+ TReg from activated CD4
+ T cells (see 
Appendix 2, Figure A2-4).  A similar frequency of CD4+ T cells in the BAL 
expressed Foxp3 (14.3%) as compared to the spleens or LDLN (17.4-19.4%).  
TReg frequency within the total airway CD4
+ T cell population was roughly 
equivalent to that seen in the secondary lymphoid tissues. 
The production of IL-4 and IFN  by CD4+ lymphocytes was examined by 
intracellular flow cytometric analysis performed after a brief period of in vitro 
stimulation as described in the methods (Figure 4-3).  There was an absence of 
cytokine-producing effector CD4+ T cells isolated from the spleens of naïve mice 
and from the spleens and LDLN of mice exposed to A. fumigatus four times.  In 
contrast, IL-4+ and IFN + CD4+ T cells were routinely recovered from the airway 
in roughly equal frequencies (~11-12%).  It is noted that there is a background 
frequency of IFN + cells (~3%) in the secondary lymphoid tissues, including the 
naïve spleen, but that IL-4 production was only measured in the BAL cells in this 
assay.  
In order to deplete CD4+ T cells, anti-CD4 antibody was administered prior 
to and throughout the period of exposure to exposure to A. fumigatus.  Greater 
than 99% of CD4+ T cells were depleted as determined by flow cytometric 
analysis of spleen, LDLN and BAL cells (see Appendix 2, Figure A2-5). 
The ability of CD4+ T cell-depleted mice to prevent an A. fumigatus 
infection was confirmed by histological examination of silver-stained lung tissues.  
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Fungal growth was not observed in control or CD4+ T cell-depleted mice that 
repeatedly inhaled conidia (Figure 4-4). 
After three exposures to conidia, cellular inflammation in the lung was 
examined in H&E stained lung tissue sections (Figure 4-5).  Substantial 
leukocytic infiltration was apparent in the peribronchial and peribronchiolar areas 
of control mice, but inflammation was markedly attenuated in anti-CD4 treated 
mice.  
The number of cells recruited to the airways was quantified after the 
recovery of cells by BAL (Figure 4-6).  Depletion of CD4+ cells abrogated the 
accumulation of cells in the airways that was noted in control mice after the third 
exposure to conidia. 
 To characterize the airway cellular infiltrate, flow cytometric leukocyte 
differential analysis was performed on cells recovered after three exposures to A. 
fumigatus conidia from control or anti-CD4-treated mice (Figure 4-7).  In the 
absence of CD4+ cells, the innate immune response remained intact as 
evidenced by the recruitment of neutrophils.  On the other hand, the 
hypersensitivity response, as evidenced by the influx of lymphocytes and 
eosinophils, was dependent on the presence of CD4+ cells.   
  The levels of cytokines in the BAL fluid (BALF), collected from control and 
anti-CD4-treated mice, were measured by ELISA (Figure 4-8).  The innate pro-
inflammatory cytokine TNF  was detected in the airways of both control and anti-
CD4 treated mice after repeated exposure to A. fumigatus.  The TH2 cytokine IL-
5 was only detected when CD4+ cells were present.  The production of another 
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TH2 cytokine, IL-4, exhibited a pattern similar to that of IL-5 (see Appendix 2, 
Figure A2-6).  None of the aforementioned cytokines were detectable in the 
airways of naïve mice (previous observations). 
 The capacity of CD4+ T cells to drive the AAD was tested by the adoptive 
transfer of naïve or A. fumigatus-primed CD4+ T cells into a naïve recipient that 
was subsequently exposed to conidia two times.  Control, naïve CD4+ T cells 
were purified from the spleens of naïve mice.  A. fumigatus-primed CD4+ T cells 
were purified from the combined lung and lung-draining lymph node tissues of 
mice previously exposed to conidia three times.  CD4+ T cells were purified to 
greater than 90% with a combination of negative and positive selection with 
magnetic beads (see Appendix 2, Figure A2-7).  0.8-1 107 purified CD4+ T cells 
were transferred to naïve recipients, and on the same day they received the first 
of two weekly exposures to conidia.  A recipient control group received only a 
PBS vehicle i.v. injection.  Airway cellular inflammation in the recipient mice was 
quantified after the recovery of cells by BAL 24 hours after the second inhalation 
of conidia (Figure 4-9).  Vehicle control- and naïve CD4+ T cell-recipient mice had 
similar numbers of airway leukocytes that were comparable to the response seen 
in previous experiments in naïve mice after two exposures.  By comparison, A. 
fumigatus-primed CD4+ T cell-recipient mice had a several-fold, significant 
increase in the number of airway cells. 
 To characterize the leukocytic infiltrate, the cells recovered from the 
airways of recipient mice were analyzed by flow cytometric leukocyte differential 
analyses (Figure 4-10).  The adoptive transfer of A. fumigatus-primed CD4+ T 
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cells, but not vehicle or naïve CD4+ T cells, promoted the allergic airways 
response, evidenced by significantly greater numbers of lymphocytes and 
eosinophils.   
 Transferred CD4+ T cells were labeled with CFSE in order to monitor their 
trafficking and proliferation in the recipient mice (Figure 4-11).  Approximately 5% 
of the total CD4+ T cell population was identified by the CFSE label in the mice 
that received A. fumigatus-primed CD4+ T cells.  The CFSE profile indicated that 
the cells had undergone various rounds of cell division, thereby diluting the CFSE 
stain.  It is possible that additional donor A. fumigatus-primed CD4+ T cells were 
not distinguished from host CD4+ T cells, because the CFSE had been diluted to 
the background level of unstained cells.  In marked contrast, less than 0.5% of 
the total CD4+ cell population was CFSE+ in the mice that received naïve CD4+ T 
cells.  Furthermore, the CFSE+ cells from the naïve donors did not exhibit any 
sign of proliferation in the recipients after exposure to A. fumigatus.   




Figure 4-1.  A significant increase in airway CD4+ T cells corresponds to the 
onset of the allergic airways disease. 
Cells recovered from the airway were analyzed for expression of CD4 on 
lymphocytes as described in the materials and methods.  Mean (+SEM) of cell 
numbers compiled from the means of two independent experiments are shown.  
Note:  In previous experiments, the number of CD4+ T cells present in the 





Figure 4-2.  Activated CD4+ T cells are localized exclusively to the effector 
site. 
As described in the materials and methods, cells were collected from various 
tissues (including spleen, lung draining-lymph nodes (LDLN), and airway (BAL)) 
from untreated mice and mice exposed to A. fumigatus four times (n=3 per 
group) as indicated above the figure.  Cells were pooled for analysis.  Gated 
CD4+ lymphocytes were analyzed for expression of the activation markers CD25, 
CD44 and CD69 by flow cytometry (see axes labels for contour plots).  
Quadrants were set with isotype control-stained CD4+ lymphocytes (not shown) 
and the percentage of CD4+ lymphocytes in each quadrant is included on each 







Figure 4-3.  CD4+ T cells exhibit a mixed TH1/TH2 subset profile at the effector site. 
As described in the materials and methods, cells were collected from various tissues 
from untreated mice and mice exposed to A. fumigatus four times (n=3 per group) and 
analyzed for cytokine production by flow cytometry.  Pooled cells for each group were 
briefly activated in vitro for 5h with PMA and ionomycin in the presence of monensin in 
order to enhance cytokine production and block its secretion, respectively.  A) Gated 
CD4+ lymphocytes were analyzed for the intracellular accumulation IFN  and IL-4 (see 
axes labels for contour plots).  Quadrants were set with intracellular isotype control-
stained CD4+ lymphocytes (top row) and the percentage of CD4+ lymphocytes in each 
quadrant is included on each plot.  An independent, repeat experiment produced similar 
results.  B) The bar graph depicts data collected from four independent experiments with 
cells recovered by BAL from mice exposed to A. fumigatus three or four times (note 
three and four exposures produced similar data).  The data show the mean (+SEM) 




Figure 4-4.  In the absence of CD4+ T cells, Aspergillus fumigatus does not 
escape host protection in the lungs of mice after repeated, weekly 
inhalation of viable conidia. 
As described in the materials and methods, one group of mice was treated with 
anti-CD4 antibody prior to and throughout the period of three exposures, while 
another group was exposed but not treated with depleting antibody.  Histological 
sections of lung tissue were stained with Gomori Methenamine Silver in order to 
detect fungal material, which is stained black.  Representative photomicrographs 




Figure 4-5.  The absence of CD4+ T cells results in severely attenuated 
inflammation of the lungs. 
Mice in both groups were exposed to A. fumigatus three times, and not treated or 
treated with anti-CD4.  Histological sections of lung tissues stained were with 
H&E.  Representative micrographs include terminal bronchioles.  Black bars are 




Figure 4-6.  CD4+ cells mediate the accumulation of leukocytes in the 
airway to a large extent. 
Mice in both groups were exposed to A. fumigatus three or four times, and not 
treated or treated with anti-CD4 (note: three or four exposures produced similar 
results).  Cells were recovered from the airway and enumerated under a 
microscope with a hemacytometer.  Mean (+SEM) of cell numbers compiled from 





     
     
 
Figure 4-7. CD4+ T cells are necessary for the manifestation of cellular allergic 
airway inflammation. 
Mice in both groups were exposed to A. fumigatus three or four times, and not treated or 
treated with anti-CD4 (note:  three or four exposures produced similar results).  Cells 
were recovered from the airway and a leukocyte differential was performed with flow 
cytometry according to the method described in Appendix 1.  A) Representative density 
plots show expression of CD11c and Gr1 for the entire airway cell populations.  The 
central densities of individual leukocyte subpopulations are labeled (M=macrophage, 
N=neutrophil, L=lymphocyte, and E=eosinophil).  B) The product of the percentage of 
each leukocyte subset and the total airway cell number gives the cell numbers for each 
leukocyte subset present in the airways (see y-axis labels).  Mean (+SEM) of cell 
numbers compiled from the means of three independent experiments are shown. 
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Figure 4-8.  CD4+ T cells are necessary for the production of a TH2 cytokine 
but not an innate inflammatory cytokine.  
Mice in both groups were exposed to A. fumigatus three times, and not treated or 
treated with anti-CD4.  Cytokines present in the cell-free BALF were quantified by 
ELISA.  The graph depicts the mean (+SEM) for individual samples (n=3 per 
group).  An independent, repeat experiment produced similar results.  Note:  In 





Figure 4-9.  The transfer of A. fumigatus-primed, but not naïve, CD4+ T cells 
promotes a significantly enhanced cellular response to inhaled conidia. 
After the adoptive transfer of vehicle control ( ) or 0.8-1 107 purified CD4+ T 
cells, recipient mice were exposed to conidia on the day of transfer and a week 
later, 24h before cells were collected from the airway.  As described in the 
methods, naïve CD4+ T cells were purified from the spleens of naïve animals, 
and Af-primed CD4+ T cells were purified from a pool of lung leukocytes and 
lung-draining lymph node cells harvested from mice exposed to conidia three 
times.  The graph depicts the mean (+SEM) for individual samples (n=4 per 
group) of total cells recovered from the airways of recipient mice post A. 






Figure 4-10.  The transfer of A. fumigatus-primed, but not naïve, CD4+ T 
cells accelerates the development of the allergic airways response. 
As described previously, recipient mice were exposed to conidia on days 0 and 7 
after the adoptive transfer of vehicle control ( ) or 0.8-1 107 purified CD4+ T 
cells.  Cells were collected from the airways of recipient mice 24h after the 
second exposure, and leukocyte differential analyses were performed on 
individual samples.  The graph depicts the mean (+SEM) number of cells for 





Figure 4-11.  Transferred A. fumigatus-primed, but not naïve, CD4+ T cells 
undergo cellular division and accumulate at the effector site. 
As described previously, recipient mice were exposed to conidia on days 0 and 7 
after the adoptive transfer of vehicle control ( ) or 0.8-1 107 purified, CFSE-
labeled CD4+ T cells.  Cells were collected from the airways of recipient mice 24h 
after the second exposure and pooled for flow cytometric analyses.  Shown 
above are the CFSE profiles of the gated CD4+ T cell populations, including 
endogenous recipient cells and transferred donor cells (shaded histograms).  
Endogenous recipient cells are CFSE-. Arrows point to distinct peaks of donor 
CFSE+CD4+ T cells, where peaks of reduced intensity are evidence of previous 
cell division. The CFSE intensity of each donor cell population at the time of 
transfer is overlayed onto each respective plot for reference (open histograms), 
but note that these cells were analyzed by flow cytometry at a previous, separate 
session due to the length of the experiment and the amplitude of the donor cell 
peak is not relevant. The percentage of CD4+ T cells in the recipient airways that 
are CFSE+ are labeled on each histogram, but note that additional donor cells 





 The data presented in this chapter demonstrated that CD4+ T cells 
mediated the hypersensitivity response to A. fumigatus after repeated inhalation 
of viable conidia.  After three weekly exposures, a significant increase in the 
number of activated, cytokine producing CD4+ TH cells in the airway coincided 
with the onset of the hypersensitivity response that manifested as an AAD.  CD4+ 
T cells were required for the pathogenesis of the hypersensitivity disease, 
because depletion of CD4+ T cells throughout the period of exposure to conidia 
severely abrogated the AAD but did not affect fungal clearance.  Finally, the 
adoptive transfer of A. fumigatus-primed, but not naïve, CD4+ T cells augmented 
the development of the AAD. 
  In the present study, activated and terminal effector CD4+ T cells were 
recovered exclusively from the airways.  Specifically, BAL CD4+ T cells, but not 
spleen or LDLN CD4+ T cells, had increased expression of the activation markers 
CD25, CD44, and CD69 and an increased production of the effector cytokines IL-
4 or IFN .  These data on the compartmentalization of CD4+ T cell activation and 
cytokine production are consistent with previous reports on the generation of 
CD4+ TH1 cell responses to pulmonary fungal infections
7, 15.  Recently, the 
priming of TH1 cells was analyzed in the context of pulmonary infections with the 
fungi Aspergillus fumigatus and Cryptococcus neoformans7, 15.  In both studies, 
the proliferative capacity of CD4+ T cell population resided with those cells in the 
LDLN, but activated, IFN -producing effector CD4+ TH1 cells resided exclusively 
at the site of infection.  The pattern of TH1 differentiation during fungal infection 
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was similar to that reported in the context of a pulmonary infection with influenza 
virus16.  Our findings suggested that CD4+ TH2 cell priming likely occurs in a 
similar fashion.  It is interesting that activated, cytokine-producing TH2 cells seem 
to be restricted to the lung during the allergic response considering the critical 
role of TH2 cells and TH2 cytokines in promoting IgE production by germinal 
center B cells residing in secondary lymphoid organs17, 18.  While lymph node-
resident dendritic cells prime CD4+ TH1 cells by antigen presentation and IL-12 
production, dendritic cells do not produce IL-4, so the spatiotemporal 
organization of CD4+ TH2 priming is more complex and not currently well 
understood19-21.  Our model provides further opportunity to study the regulation of 
the development of a TH2 immune response to an inhaled allergen. 
 Repeated exposure to viable A. fumigatus conidia induced CD4+ TH2 and 
TH1 cells.  Several previous reports indicated that a single exposure to A. 
fumigatus conidia led primarily to the priming of CD4+ TH1 cells
6, 7, and exposure 
to A. fumigatus hyphae or antigen extracts led primarily to the priming of CD4+ 
TH2 cells
6, 9.  Systemic priming and airway exposure to A. fumigatus antigens 
established a TH2-mediated AAD that was subsequently augmented by exposure 
to conidia, suggesting at least that pre-formed CD4+ TH2 cells would respond to 
conidia8.  Differences in the CD4+ T cell response to conidia likely depended on 
the dosing and frequency used in the various studies.  In the aforementioned 
studies that resulted in primarily CD4+ TH1 priming, 5 and 100 times the number 
of conidia used in our study were administered6, 7.  A differential effect of dose 
and frequency of exposure to A. fumigatus conidia may have clinical relevance, 
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because TH1-associated hypersensitivity pneumonitis results from very high-dose 
exposure, generally in an occupational setting22-25. 
 It is interesting that in spite of the presence of TH2 and TH1 cells, the CD4
+ 
T cell-dependent hypersensitivity disease that developed after repeated 
exposure to conidia had many features of AAD, a TH2 disease.  Previously, TH1 
cells were reported to abrogate TH2 cell-mediated AAD
26.  However, it is also 
noted that TH1 responses to viral infections are known to exacerbate asthma 
symptoms27, 28.  Furthermore, it was recently demonstrated in mice that a TH1-
promoting rhinovirus infection augmented a TH2 allergic airway disease, and that 
the pre-existing TH2 allergic airway disease augmented the TH1 response to 
rhinovirus infection29.  The data generated in the present study support the 
emerging understanding that asthma and allergic diseases are not simply the 
result of an imbalance in counterregulatory TH1 and TH2 responses
30.  Rather, 
current evidence suggests that TH2 and TH1 responses are both inflammatory, 
and are both subject to control by myriad regulatory mechanisms, such as those 
mediated by dedicated regulatory T cells. 
  In our experiments, clearance of A. fumigatus was not impaired by either 
CD4+ T cell depletion or the development of a CD4+ TH2 cell response.  It has 
been reported in murine models of invasive pulmonary aspergillosis that CD4+ 
TH1 cells enhance protection, and CD4
+ TH2 cells enhance susceptibility
31-34.  It 
was likely that TH1 cells were better able to promote the restoration of functional 
innate immunity following certain treatments that impaired macrophage or 
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neutrophil responses.  The participation of CD4+ T cells in the clearance of 
inhaled conidia is probably not required if the innate immune response is intact. 
 In the present study, we found that CD4+ cell depletion throughout the 
period of A. fumigatus exposure ablated airway eosinophilia and BALF IL-5 
production.  It has been recognized for some time that production of IL-5 is 
critical for the orchestration of tissue eosinophilia35-37.  In turn, TH2 cells are 
widely regarded as the critical source of IL-5 in the allergic response38.  However, 
recent evidence demonstrated that innate immune cells were able to promote 
tissue eosinophilia in response to chitin, a fungal product, and purified 
Aspergillus oryzae protease in RAG-deficient mice that lack functional CD4+ T 
cells12, 13.  In the present study, airway inflammation was examined after several 
weekly exposures to conidia, so it is possible we failed to detect an early wave of 
innate immune activity, including eosinophil recruitment.   
 The introduction of A. fumigatus-primed CD4+ T cells into naïve mice 
augmented the development of the AAD in response to subsequent inhalation of 
conidia.  In agreement with our previous observations (see Chapter 3), two 
exposures to conidia did not induce a robust allergic response.  However, mice 
that received A. fumigatus-primed CD4+ T cells, but not naïve CD4+ T cells, 
exhibited a robust allergic response.  The magnitude of the response was 
comparable to measured after naïve mice were exposed to conidia three or four 
times (see Chapter 3).  Therefore, a rate-limiting step in the development of the 
AAD was the priming of the CD4+ T cell response.  
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 In conclusion, CD4+ T cells mediated the hypersensitivity response to A. 
fumigatus.  The CD4+ T cell response was comprised of relatively equal 
frequencies of TH2 and TH1 cells.  In addition, TH17 cells were present at 
frequencies similar to those for TH2 and TH1 cells (see Figure 5-3).  This model 
affords further opportunity for investigation into the TH cell response to the 
inhalation of a natural respiratory allergen, including local TH cell differentiation 
and unique TH cell subset effects.  In addition, this model affords the opportunity 
to investigate the chronic effects of a CD4+ T cell-mediated hypersensitivity 
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Rationale   
 Hypersensitivity responses can lead to severe disease when the 
inflammation becomes chronic.  In humans, the pathogenesis of asthma is 
routinely described as a progression through the following stages:  acute 
inflammation, chronic inflammation, and airway remodeling.  Chronic 
inflammation is associated with nonspecific bronchial hyperreactivity, and chronic 
inflammation promotes airway remodeling.  Airway remodeling is associated with 
reversible airways obstruction.  Bronchial hyperreactivity and reversible airways 
obstruction result in the manifestation of the clinical disease asthma1.  In Chapter 
4, the acute allergic airway response to viable Aspergillus fumigatus conidia did 
not result in augmented airway hyperreactivity.  Previously published murine 
models do not recapitulate all the clinical features of the human disease asthma, 
especially the maintenance of chronic inflammation2.    
 
Hypothesis 
 Due to the inherent allergenicity of viable A. fumigatus conidia, chronic 




1. To determine the strength and character of the local immune response 
after chronic exposure to viable A. fumigatus conidia via continued, 
weekly inhalation. 
2. To determine the extent of histopathological alterations in the lung after 
chronic exposure to conidia. 
3. To determine the extent of pathophysiological alterations in pulmonary 
function after chronic exposure to conidia. 
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RESULTS 
 To determine if chronic exposure to A. fumigatus conidia led to 
progressive inflammation, the extent of the allergic airway disease (AAD) was 
evaluated in mice 24 hours after the last of 4 and 8 weekly exposures.  The 
severity of the inflammatory response was examined by the quantification of the 
airway leukocytes recovered by bronchoalveolar lavage (BAL) (Figure 5-1).  
Similar numbers of total cells were recovered from the airways after four and 
eight exposures.  Cellular inflammation was persistent, but not progressive, 
during the transition from acute (4 exposures) to chronic (8 exposures) 
inflammation. 
 Leukocyte different counts were generated by flow cytometric analysis of 
cells recovered from the airway (Figure 5-2).  There were no significant 
differences for any particular leukocyte subset, though macrophages were 
slightly increased and eosinophils were slightly decreased after eight as 
compared to four exposures.  The numbers of neutrophils and lymphocytes were 
very similar at both time points. 
 The functional capacity of effector CD4+ TH cells to produce cytokines was 
analyzed by intracellular cytokine staining and flow cytometry with cells 
recovered from the airway (Figure 5-3).  Only cells recovered from the airway 
(BAL), and not the lung-draining lymph nodes (LDLN), produced detectable 
amounts of cytokines as measured by this method (see Chapter 4).  After four 
exposures, approximately 10-15% of CD4+ T cells produced IL-4, IFN , or IL-17.  
The percent of IL-17-producing CD4+ T cells significantly increased after long-
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term exposure.  There was a modest, but not significant, decrease in the 
frequency of CD4+ T cells producing IL-4.  Finally, the proportion of CD4+ T cells 
producing IFN  was similar after four or eight exposures.  Note, the absolute 
numbers of CD4+ T cells recovered from the airways after four and eight 
exposures was similar (see Appendix 2, Figure A2-8). 
 The levels of serum total IgE were measured by ELISA in blood samples 
collected at the time of harvest (Figure 5-4).  An elevated level of total IgE, 
present after four exposures, persisted with chronic exposure.   
 Histological samples of lung tissue were stained with PAS to reveal mucus 
in the airways (Figure 5-5).  Goblet cell metaplasia and mucus hypersecretion 
were prominent after four exposures and persisted with chronic exposure.  
Airways obstruction with mucus was not regularly detected and did not increase 
with chronic exposure. 
 Histological samples of lung tissue were stained with Masson’s trichrome 
in order to examine the peribronchial collagen (Figure 5-6).  In naïve control 
mice, a thin layer of blue-stained collagen supported the peribronchial smooth 
muscle.  A single layer of mesenchymal cells, identified by their spindle-shaped 
nuclei, was associated with the collagen layer in naïve mice.  After four 
exposures, there was increased collagen staining in the peribronchial area.  After 
eight exposures, modest remodeling was noted in that there were often several 
layers of collagen-associated mesenchymal cells, identified by rows of nuclei 
adjacent to the epithelium. 
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 Peribronchial smooth muscle was evaluated by immunohistochemistry of 
lung sections stained with anti-  smooth muscle actin ( -SMA) antibody (Figure 
5-7).  AAD resulting from repeated exposure to A. fumigatus did not result in 
remodeling of the peribronchial smooth muscle layer at early or late time points. 
 The airway response to methacholine provocation in mice exposed to 
conidia four and eight times was compared to the airway response in naïve mice 
(Figure 5-8).  Mice with acute or chronic allergic airway inflammation did not 





Figure 5-1.  Cellular inflammation in the airway is maintained with chronic 
exposure to conidia.  
Cells were recovered from the airway by bronchoalveolar lavage and 
enumerated under the microscope with a hemacytometer.  These data were 
collected from four independent experiments for each group, containing three or 
mice per group per experiment.  The mean value for each group in each 
experiment was compiled.  The graph illustrates the mean (+ SEM) number of 
total cells present in the airways 24h after 4 or 8 weekly exposures.  
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Figure 5-2.  Subtle changes in airway leukocyte subsets result from chronic 
exposure. 
After 4 or 8 weekly exposures to A. fumigatus, cells were recovered from the 
airways, and leukocyte differential analyses were performed with flow cytometry 
according to the method described in Appendix 1.  The product of the percentage 
of each leukocyte subset and the total airway cell number gives the cell numbers 
for each leukocyte subset present in the airways (i-iv, see y-axis labels).  Mean 
(+SEM) of cell numbers compiled from the means of three independent 







Figure 5-3.  The frequency of airway TH subsets is variably affected by chronic exposure.  
Cells were collected from the airways of mice exposed to A. fumigatus 4 or 8 times (n=3 per 
group) and analyzed for cytokine production by flow cytometry, as described in the materials and 
methods.  Pooled cells for each group were briefly activated in vitro for 5h with PMA and 
ionomycin in the presence of monensin in order to enhance cytokine production and block its 
secretion, respectively.  A) Gated CD4
+
 lymphocytes were analyzed for the intracellular 
accumulation IFN , IL-4, and IL-17 (see axes labels for density plots).  Quadrants were set with 
the aid of intracellular isotype control-stained CD4
+
 lymphocytes (not shown) and the percentage 
of CD4
+ 
lymphocytes in each quadrant is included on each plot.  An independent, repeat 
experiment produced similar results.  B) The bar graph depicts data collected from three 
independent experiments (two experiments included IL-17).  The data show the mean (+SEM) 
percentage of CD4
+
 lymphocytes expressing the specific cytokine after four or eight exposures.  




Figure 5-4.  Elevated levels of serum IgE are maintained with chronic 
exposure. 
Mice were exposed to A. fumigatus 4 or 8 times on a weekly basis.  Blood was 
collected 24h after the final exposure.  Total IgE levels in the serum were 
quantified by ELISA.  Data for individual mice was compiled from 5 independent 




Figure 5-5.  Goblet cell metaplasia and mucous hypersecretion persist with 
chronic exposure. 
Histological sections of lung tissue were stained with PAS in order to detect 
mucous, which is stained purple.  Representative photomicrographs include 
conducting airways from mice exposed to A. fumigatus 0, 4 or 8 times at weekly 




Figure 5-6.  Remodeling of the peribronchial collagen layer develops after 
repeated exposure. 
Histological sections of lung tissue were stained with Masson’s trichrome in order 
to detect collagen, which is stained blue.  Representative photomicrographs 
include conducting airways from mice exposed to A. fumigatus 0, 4 or 8 times at 




Figure 5-7.  Thickening of the peribronchial smooth muscle layer does not 
occur after repeated exposure. 
As described in the methods, histological sections of lung tissue were stained 
with standard immunohistochemistry techniques in order to identify smooth 
muscle cells, which are stained brown.  The bottom row contains sections 
stained with anti-  smooth muscle actin and the appropriate secondary antibody 
while the top row contains adjacent sections stained with secondary antibody 
only.  Representative photomicrographs include conducting airways from mice 





Figure 5-8.  Airway hyperreactivity does not develop after repeated 
inhalation of A. fumigatus conidia. 
As described in the methods, bronchial resistance was measured in a whole 
body plethysmograph 24h after a given number of exposures (see bar graph 
legend).  Briefly, resistance values were calculated in real-time for anesthetized 
and ventilated mice at baseline and after direct respiratory challenge with 20μl of 
a nebulized methacholine solution (see x-axis labels) at doses previously 
determined to elicit significant responses in hyperreactive mice.  Mean (+SEM) 
for four-to-five mice per group are shown.  An independent experiment with 
unchallenged mice and mice exposed four times produced similar results. 
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DISCUSSION  
 The data presented in this chapter demonstrated that pulmonary 
inflammation persisted, but did not progress, with chronic exposure to viable A. 
fumigatus conidia.  Features of the AAD that were similar in severity between the 
acute and chronic inflammatory phases included the number of leukocytes 
present in the airways, the level of serum total IgE, and the presence of mucus 
hypersecretion.  While the total number of CD4+ T cells in the airways was similar 
at both time points, the proportions of CD4+ TH subsets were dynamic.  After four 
exposures, there were roughly equivalent frequencies of cytokine-producing TH1, 
TH2, and TH17 cells (~10-15% of total CD4
+ T cells).  However, by eight 
exposures, the frequency of TH2 cells was moderately decreased, and the 
frequency of TH17 cells was significantly increased.  Evidence of mild airway 
remodeling was found, but remodeling was not progressive.  As was the case 
with acute inflammation, chronic inflammation to A. fumigatus conidia did not 
result in increased AHR. 
 In the present study, airway eosinophilia persisted with chronic 
inflammation.  While the total number of eosinophils was reduced compared to 
the peak levels detected during acute inflammation, the number of eosinophils 
present during the chronic phase of inflammation was higher than that seen in 
naïve mice (see Chapter 3).  Attenuated airway eosinophilia with chronic 
exposure is a common finding in murine models of AAD.  For instance, airway 
eosinophilia and increased AHR developed with acute exposure lasting 10 days 
in OVA-sensitized mice, but were attenuated with chronic exposure lasting more 
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than six weeks3.  Likewise, acute airway eosinophilia peaked after ~3 weeks of 
repeated inhalation of A. fumigatus antigens, but airway eosinophilia declined at 
later time points with continued exposure4, 5.  The effect of attenuated airway 
eosinophilia is not well understood, in part because the role of eosinophils in the 
mouse appears to be limited compared to their role in humans6. 
 In our study, a modest, but insignificant, decline in the frequency of TH2 
cells within the airway population of CD4+ T cells accompanied the modest 
reduction in the number of airway eosinophils during the progression from acute 
to chronic exposure.  The attenuation of airway eosinophilia with chronic 
exposure to allergen in OVA-sensitized mice was associated with diminished TH2 
cell activities7.  Chronic inflammation is central to the pathogenesis of asthma, 
because it induces airway remodeling.  While TH2 activity declined with continued 
exposure to viable conidia, TH1 activity was maintained and TH17 activity was 
increased, so CD4+ T cell-mediated pro-inflammatory influences persisted. 
 In our study, chronic exposure to A. fumigatus led to mild, but not 
progressive, airway remodeling.  Goblet cell metaplasia and mucus 
hypersecretion was detected in the acute and chronic phases of inflammation.  
We noted an increase in the peribronchial collagen, and an increase in the 
number of layers of parenchymal cells, possibly collagen-producing fibroblasts, 
associated with the peribronchial collagen layer.  We did not detect thickening of 
the peribronchial smooth muscle layer at any point during the inflammatory 
response.   Chronic inflammation and varying degrees of airway remodeling have 
been reported in other studies with mice8-10.  In those reports, chronic 
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inflammation and peribronchial fibrosis were detected in OVA-sensitized and 
challenged mice, house dust mite (HDM) exposed mice, and A. fumigatus 
antigen-sensitized and conidia exposed mice.  Increased peribronchial smooth 
muscle also was reported in the studies with OVA and HDM.  In every case, 
airway remodeling was associated with persistent cellular inflammation and AHR.  
Airway remodeling is a central feature of asthma, but in general murine models of 
AAD have not exhibited a strong propensity towards airway remodeling. 
 Chronic exposure to A. fumigatus conidia in the present study did not 
result in interstitial fibrosis or fungal colonization of the airways.  A. fumigatus is 
implicated in hypersensitivity pneumonitis (HP), a hypersensitivity disease 
associated with a TH1 immune response to inhaled organic particles
11-13.  In HP, 
chronic inflammation can result in severe interstitial fibrosis14, 15.  Those with 
asthma are at heightened risk for the development of allergic bronchopulmonary 
aspergillosis (ABPA), a severe TH2-mediated hypersensitivity disease driven by 
the colonization of the airway with A. fumigatus.  Chronic, repeated exposure to 
viable A. fumigatus conidia did not lead to the development of pathological 
features found in HP or ABPA. 
 In the present study, the progression from acute to chronic inflammation 
was accompanied by a significant increase in the frequency of TH17 cells, but the 
number of neutrophils in the airway remained relatively constant.  TH17 cells are 
implicated in the pathogenesis of a variety of chronic inflammatory disorders, 
including autoimmune and allergic disorders16.  It is clear that IL-17 has an 
important role in mediating pathology in a variety of diseases, but the mechanism 
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by which IL-17 acts is not well understood17.  One important mechanism of action 
for IL-17 seems to be the recruitment of neutrophils to the site of inflammation18.  
In allergic airway disease, anti-IL-17 treatment simultaneously abrogated 
neutrophil recruitment and enhanced IL-5 production and eosinophil recruitment, 
suggesting these pathways may be reciprocally regulated19.  In response to 
chronic exposure to A. fumigatus conidia, the increased TH17 response was 
associated with a decreased TH2 response.  The pathological significance of the 
TH17 response in this setting remains to be determined. 
 In conclusion, chronic exposure to viable A. fumigatus conidia resulted in 
persistent, but not progressive, airway inflammation.  Polarized CD4+ TH1, TH2, 
and TH17 cells were present in the airway, and the relative frequencies of the TH 
subsets were dynamically regulated during the progression from the acute to the 
chronic phase of inflammation.  Our model provides a further opportunity to 
investigate the pathological effects of chronic pulmonary inflammation, and a 
further opportunity to study the regulation of TH subset dynamics and the role of 
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Hypersensitivity Response to Aspergillus fumigatus:  Pathogenesis of 




 Emerging evidence suggests that chronic pulmonary inflammation 
associated with allergic airway disease (AAD) could represent a novel pathway 
for the pathogenesis of pulmonary arterial remodeling.  In asthma patients, 
bronchial arteries exhibited an increase in intimal area, associated with smooth 
muscle proliferation and calcification of the elastica, and a corresponding 
decrease in luminal area1.  In a murine model, recent data indicated that a 
prolonged TH2 cell-mediated immune response to inhaled soluble antigen 
induced remodeling of pulmonary muscular arteries2.  Another murine study 
demonstrated increased proliferation by various cellular components of small 
pulmonary arteries in the context of acute allergic inflammation3.  Remodeling of 
small-to-medium-sized muscular arteries in the lung is central to the 
pathogenesis of pulmonary arterial hypertension (PAH).  PAH is a disease with 
considerable morbidity and mortality owing to increased pressure within the 
pulmonary vasculature that can lead to right-sided heart failure.  Chronic 
inflammation may play a role in the pathogenesis of PAH4.  In Chapter 5, chronic 





 Immunopathological alterations in pulmonary arterial anatomy and 
physiology will result from chronic inflammation in the lung promoted by 
repeated, weekly inhalation of viable A. fumigatus conidia. 
  
Objectives 
1. To determine the association between the histopathogenesis of pulmonary 
arterial remodeling and the inflammatory response to viable A. fumigatus 
conidia during continued exposure. 
2. To determine the extent of pathophysiological alterations in pulmonary 
circulation after chronic exposure to conidia. 
3. To determine the necessity for CD4+ T cell involvement in the 
pathogenesis of alterations in pulmonary artery anatomy and physiology 
after chronic exposure to conidia. 
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RESULTS 
 To determine if pathological alterations to pulmonary artery anatomy and 
physiology resulted from chronic allergic airways inflammation a kinetic study 
was performed on mice exposed weekly to viable A. fumigatus conidia for a total 
of 0, 2, 4 or 8 exposures.  Using this protocol for exposure, the strength and 
character of the hypersensitivity response was measured previously by the 
analysis of bronchoalveolar lavage (BAL) contents (see Chapters 3, 4 and 5).  In 
this study, the extent and composition of the cellular response was measured 
after leukocytes were recovered from the whole lung in order to sample all lung 
regions, including the perivascular area (Figure 6-1).  Significant increases in 
total lung leukocytes were recorded after 4 or 8 exposures.  In each case, the 
number of cells had more than doubled compared to the number of cells present 
in untreated mice.   
 Traditional leukocyte differential counts were performed on cells recovered 
form the lung (Figure 6-2).  The number of macrophages was increased slightly 
after 4 and 8 exposures and decreased slightly after 2 exposures.  There was a 
consistent increase in neutrophils throughout the period of study to roughly 
double the number found in untreated mice.  Increased numbers of lymphocytes 
were present in the lung, particularly at the later two time points.  The number of 
eosinophils increased significantly, many-fold higher than background, peaked 
after 4 exposures, and declined to approximately half the peak-level after 8 
exposures.  These data indicate that repeated exposure to conidia resulted in 
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persistent, but dynamic, allergic pulmonary inflammation.  These data were 
similar to the data generated by analysis of BAL cells. 
 The inflammatory response to A. fumigatus induced substantial 
remodeling of small-to-medium-sized muscular arteries in the lung.  Large 
pulmonary arteries and all pulmonary veins were not affected (see Appendix 2, 
Figure A2-9 and Figure 6-7).  The remodeling process was progressive over the 
period of inflammation studied.  Histological sections of lungs were analyzed 
after staining with H&E, anti-  smooth muscle actin ( -SMA) antibody, Masson’s 
trichrome, and Verhoeff’s-van Giesen’s.  At the conclusion of the chronic 
exposure period, the cellularity of the arterial walls was markedly increased, and 
the arterial lumen was oftentimes severely occluded (Figure 6-3).  Multiple rows 
of structural-support cells, containing spindle-shaped nuclei, were apparent in the 
fully remodeled arteries (Figure 6-3).  Intermediate stages of remodeling were 
appreciated after two and four exposures.  During the intermediate period, 
nucleated cells accumulated on the luminal side of the arteries (Figure 6-3).  
Cells, probably smooth muscle cells and/or myofibroblasts, that were fully 
incorporated into the arterial wall after chronic exposure stained positive for -
smooth muscle actin (Figure 6-4).  In contrast, cells associated with the arterial 
lumen during intermediate remodeling had primarily round nuclei and did not 
stain positive for -smooth muscle actin (Figure 6-4).   
 Fibrosis of the fully remodeled arterial walls was severe as evidenced by a 
dense network of extracellular matrix material, probably collagen, that stained 
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with Masson’s trichrome (Figure 6-5).  On the other hand, fibrosis of the arterial 
wall was not extensive at the intermediate stages of remodeling (Figure 6-5).   
 Based on examination of elastin staining with Verhoeff’s-van Giesen’s, 
additional layers of cells in fully remodeled arteries were positioned on the 
luminal side of the interna elastica, indicative of neointimal formation (Figure 6-6).  
The elastic basement membranes were difficult to visualize in many remodeled 
arteries, probably because they were disrupted in the pathological process.  
However, it was concluded that neointimal formation was part of the remodeling 
spectrum based on the visualization of the interna elastica in a fraction of 
vessels.  
 The muscularization of small-to-medium-sized arteries throughout the 
lungs was quite extensive (Figure 6-7).  Whole organ histopathological 
examination of lungs suggested that remodeling developed primarily in inflamed 
areas of the lung.  Hyphal invasion of the arterial walls by the fungus was not 
detected with GMS stain though background staining of affected arteries was 
noted (see Appendix 2, Figure A2-10). 
 Our previous data indicated that CD4+ T cells mediated the acute allergic 
inflammatory response to repeated inhalation of A. fumigatus conidia (see 
Chapter 4).  To determine the role of CD4+-mediated inflammation on the arterial 
pathology detected with chronic exposure, one group of mice was treated with 
anti-CD4 antibody throughout the period of eight exposures to conidia.  Based on 
histological examination of the lung, the absence of CD4+ T resulted in a severely 
attenuated inflammatory response (Figure 6-8).   
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 In order to quantify the extent of lumen narrowing, morphometric analysis 
was undertaken (Figure 6-9).  Arteries were selected from the lungs in random 
fashion using an automated microscope apparatus.  The cross-sectional areas of 
the artery and the patent lumen were measured in a blinded fashion.  Chronic 
exposure resulted in a significantly decreased ratio of patent lumen to total artery 
cross-sectional areas.  In untreated mice, the lumen area was 58% ± 12% (mean 
± SD).  After eight exposures, the lumen area was reduced to 29% ± 14%.  Anti-
CD4 treatment throughout the period of exposure inhibited some, but not all, of 
the arterial remodeling.  After eight exposures in the absence of CD4+ cells, the 
lumen area was 40% ± 12%.  In the A. fumigatus-exposed, anti-CD4-treated 
group, the luminal patency was significantly greater than that of the A. fumigatus-
exposed group but significantly reduced compared to the untreated group.  Anti-
CD4 treatment protected the A. fumigatus-exposed mice from the most severe 
narrowing as evidenced by the relative paucity of arteries with less than 25% 
lumen area in the doubly treated group.  These data suggest that CD4+ T cells 
participated in the pathogenesis of arterial remodeling, but that some degree of 
remodeling was CD4+ T cell-independent. 
 Significant pulmonary arterial lumen narrowing can lead to increased 
pulmonary arterial pressure.  The systolic pressure within the right ventricle was 
measured in order to gauge pulmonary arterial pressure (Figure 6-10).  In 
ventilated mice, the thoracic cavity was dissected, and a probe was inserted into 
the beating right ventricle.  Mice with chronic inflammation did not exhibit a 
significant increase in pulmonary arterial pressure, but a higher range of 
 113 
pressures was measured for mice within this group.  The range of pressures 
recorded for untreated mice was 12-34 cm H2O.  The range of pressures 
recorded for mice with chronic pulmonary inflammation was 19-48 cm H2O.  In 
the absence of CD4+ cells, right ventricular systolic pressure after chronic 
exposure was similar to that for untreated mice.   
 Increased pulmonary arterial pressure places extra burden on the muscle 
of the right ventricle and, over time, results in hypertrophy of the right ventricle.  
Chronic inflammation induced by continued exposure to A. fumigatus conidia did 
not lead to an increase in the mass of the right ventricle relative to the mass of 
the left ventricle and septum (Figure 6-11). 
 Chronic hypoxemia can induce arterial remodeling and pulmonary 
hypertension.  It is very difficult to directly measure blood gases in mice.  
Therefore, the blood hemoglobin was measured as a surrogate marker of chronic 
hypoxemia (Figure 6-12).  There were no differences between the blood 
hemoglobin levels in the various groups of mice, so evidence for compensation 




Figure 6-1.  Leukocytes accumulate in the lung after several, repeated 
exposures to A. fumigatus conidia. 
Leukocytes were recovered from the lung after mechanical disruption, enzymatic 
digestion and enrichment by a density gradient, as described in the methods.  
Lungs were harvested 24h after the final weekly exposure to A. fumigatus 
conidia, as indicated on the x-axis label.  Cells from individual mice were 
enumerated under a microscope using a hemacytometer.  The bar graph 
displays the mean (+SEM) number of cells recovered per mouse (n=6 per 
group).  All data for this experiment was collected at the same time.  These data 
are similar to independent experiments that compared each A. fumigatus group 
(2, 4 or 8 exposures) to an untreated control group.  *p < 0.01 compared to 0 






Figure 6-2.  A dynamic pattern of leukocyte subset accumulation results 
from repeated exposures. 
As described previously, lung leukocytes were recovered 24h after the final 
weekly exposure to A. fumigatus conidia.  Leukocyte differential analyses were 
performed on individual samples using standard morphological criteria, as 
described in the methods.  The bar graph displays the mean (+SEM) number of 
cells for each leukocyte subset recovered per mouse (n=6 per group).  *p < 0.05 





Figure 6-3.  Substantial remodeling causes lumen narrowing and occlusion 
of small- to medium-sized muscular pulmonary arteries after long-term, 
repeated exposure. 
Histological sections of lung tissues were stained with H&E.  Representative 
photomicrographs include medium-sized muscular arteries adjacent to 
conducting airways.  Images depict the extent of arterial remodeling present in an 
untreated sample (0) and 24h after the second, fourth or eighth weekly 





Figure 6-4.  Smooth muscle cell hyperplasia is a component of arterial 
thickening. 
As described in the methods, histological sections of lung tissue were stained 
with standard immunohistochemistry techniques in order to identify smooth 
muscle cells, which are stained brown.  The bottom row contains sections 
stained with anti-  smooth muscle actin and the appropriate secondary antibody 
while the top row contains adjacent sections stained with secondary antibody 
only.  Representative photomicrographs include medium-sized muscular arteries 
adjacent to conducting airways.  Images depict the extent of muscularization of 
the arteries present in an untreated sample (0) and 24h after the second, fourth 





Figure 6-5.  Deposition of extracellular matrix material follows the luminal 
accumulation of nucleated cells during arterial remodeling. 
Histological sections of lung tissues were stained with Masson’s trichrome in 
order to detect collagen, which is stained blue.  Representative 
photomicrographs include medium-sized muscular arteries adjacent to 
conducting airways.  Images depict the extent of collagen-containing, 
extracellular matrix deposition in the walls of the muscular arteries present in an 
untreated sample (0) and 24h after the second, fourth or eighth weekly 




Figure 6-6.  Neointimal formation contributes to arterial remodeling.   
Histological sections of lung tissues were stained with Verhoeff’s-van Giesen’s in 
order to visualize elastin.  Representative photomicrographs include medium-
sized muscular arteries adjacent to conducting airways.  Images depict the 
localization of remodeling relative to the elastic basement membranes that 
differentiate the layers of the arterial wall in an untreated sample (0) and 24h 
after the second, fourth or eighth weekly exposures (2, 4 and 8, respectively).  
The interna elastica is labeled with red asterisks in the 2 and 8 Af exposures 




Figure 6-7.  Muscularization of small- to medium-sized arteries in the lung 
is extensive. 
Histological sections of lung tissue were stained with standard 
immunohistochemistry techniques as described previously.  Smooth muscle cells 
appear brown in the section stained with anti-  smooth muscle actin (ii), but not 
in the adjacent control section stained with secondary antibody only (i).  
Representative photomicrographs highlight the extent of artery involvement (red 
asterisks).  Notice that unaffected veins appear in the upper right and lower left 




Figure 6-8.  The absence of CD4+ T cells results in severely attenuated 
inflammation of the lung. 
Mice in both groups were exposed to A. fumigatus eight times, and not treated or 
treated with anti-CD4, as described in the methods.  Histological sections of lung 
tissues stained were with H&E.  Representative micrographs include terminal 




Figure 6-9.  Arterial remodeling from repeated exposure to conidia results 
in significant lumen narrowing and is mediated at least in part by CD4+ T 
cells. 
Morphometric analyses were performed on histological sections of lung tissues in 
order to quantify the extent of arterial lumen narrowing.  Lung samples were 
collected from mice exposed or not to A. fumigatus 8 times at weekly intervals 
and treated or not with depleting anti-CD4 antibody throughout the experiment.  
An automated set-up was used to select random fields of the left lung from each 
sample and all muscular arteries obtained were measured, as described in the 
methods.  The data are presented as the cross-sectional area of the lumen 
divided by the total cross-sectional area of the vessel for all vessels with a 
length-to-width ratio less-than-or-equal-to 2.5, thereby excluding tangential artery 
sections.  Also, very small and large arteries were excluded, as explained in the 
methods.  These data were collected in two independent experiments (n=4 per 
group per experiment; except n=2-3 per group per experiment for the CD4-
treated group).  Each artery is represented by a symbol on the scatter plot, and 
the mean for each group is indicated by a horizontal line.  The dashed line at the 
y-axis value of 25% is included to aid in the comparison between groups.  The 
percentage of arteries at or below the y-axis value of 25% for each group left to 






Figure 6-10.  Significant pulmonary arterial remodeling does not promote 
pulmonary arterial hypertension. 
Pulmonary arterial pressure was measured in the right ventricle on ventilated 
mice using an open chest technique, as described in the methods.  Pressure was 
measured in mice exposed or not to A. fumigatus 8 times at weekly intervals and 
treated or not with depleting anti-CD4 antibody throughout the experiment.  The 
average systolic pressure was calculated from six consecutive heart beats for 
each mouse.  Values were only accepted from mice whose heart rate was above 
300 beats per minute in order to exclude any mice exhibiting cardiopulmonary 
distress, as explained in the methods.  Data were pooled from two independent 
experiments (n=4-5 per group).  Boxes designate the median and the 25th and 







Figure 6-11. Right ventricular hypertrophy does not develop during chronic 
A. fumigatus-induced hypersensitivity disease. 
The mass of the right ventricular free wall was determined in order to detect 
possible right ventricular hypertrophy, as described in the methods.  Tissue mass 
was measured in mice exposed or not to A. fumigatus 8 times at weekly intervals 
and treated or not with depleting anti-CD4 antibody throughout the experiment.   
The heart was dissected out and the atria were removed.  The right ventricular 
free wall was dissected away from the left ventricle and septum.  The tissues 
were weighed, and the data are presented as the mass of the right ventricular 
free wall divided by the combined mass of the right and left ventricles and the 
septum.  These data were collected in two independent experiments (n=4 per 
group per experiment; except n=2-3 per group per experiment for the CD4-
treated group). Boxes designate the median and the 25th and 75th percentiles, 




Figure 6-12.  Chronic allergic airway disease does not augment blood 
hemoglobin levels. 
The blood hemoglobin level was measured in order to detect potential 
compensation for chronic hypoxemia, as described in the methods.  Hemoglobin 
levels were measured in mice exposed or not to A. fumigatus 8 times at weekly 
intervals and treated or not with depleting anti-CD4 antibody throughout the 
experiment.   These data were collected in two independent experiments (n=4 
per group per experiment; except n=2-3 per group per experiment for the CD4-
treated group). Boxes designate the median and the 25th and 75th percentiles, 
while the whiskers designate the range. 
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DISCUSSION  
 That data presented in this chapter demonstrated that significant 
remodeling of pulmonary arteries resulted from a chronic hypersensitivity 
response to A. fumigatus.  The remodeled arteries had markedly increased 
muscularization and fibrosis of the arterial wall, and remodeled arteries showed 
signs of neointimal formation.  CD4+ T cells were required for the full 
manifestation of pulmonary inflammation and arterial remodeling.  Though mice 
developed severe arterial muscularization, arterial fibrosis, and significant luminal 
narrowing, mice did not develop PAH as a result. 
 The detection of pulmonary arterial remodeling in the present study joins a 
few other recent reports in detailing a novel mechanism for the pathogenesis of 
arterial remodeling.  In 2006, Green et al. reported that bronchial arterial 
remodeling was present in asthma patients1.  In 2008, Rydell-Tormanen et al. 
reported evidence of the induction of pulmonary arterial remodeling in mice with 
chronic allergic airway inflammation5.  Also in 2008, Daley et al. reported 
substantial pulmonary arterial muscularization developed in mice with chronic 
allergic airway inflammation2.  The present study uniquely demonstrated severe 
and extensive remodeling that was quantified by morphometric analysis of 
randomly selected lung fields.  
 In the present study, arterial remodeling, associated with the inflammatory 
response to A. fumigatus, shared many features with arterial remodeling seen in 
PAH, including severe thickening of the arterial wall and narrowing of the arterial 
lumen.  Arterial remodeling in PAH is complex, because 1) it involves all layers of 
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the arterial wall:  intima, media and adventitia; and 2) pathological changes to all 
layers result in an abnormal, heterogeneous collection of cell types6.  Another 
component of PAH is the disorganized proliferation of endothelial cells leading to 
plexiform lesions.  Such lesions were not observed in mice chronically exposed 
to conidia, but other murine models of PAH generally fail to recapitulate this 
clinical feature, as well7.   
 In this study, fully remodeled arteries contained multiple layers of cells 
expressing -SMA, likely smooth muscle cells or myofibroblasts.  In contrast, 
pulmonary arteries in untreated mice contained only a single layer of smooth 
muscle cells.  Green et al. detected smooth muscle hyperplasia associated with 
intimal thickening in bronchial arteries of asthma patients1.  After chronic 
exposure to house dust mite allergens, Rydell-Tormanen et al. measured 
increased proliferation of smooth muscle cells in walls of pulmonary arteries5.  
Daley et al. demonstrated severe arterial musclarization, very similar to that 
reported in this study, in small-to-medium-sized pulmonary arteries in allergic 
mice chronically exposed to OVA of A. fumigatus antigens2.  Smooth muscle cell 
hyperplasia and myofibroblast participation are central components of arterial 
remodeling in PAH that facilitate augmented vasoconstriction4. 
 Extracellular matrix, possibly collagen, was deposited extensively in the 
remodeled arterial walls after chronic exposure to viable conidia.  Green et al. 
detected intimal fibrosis in the bronchial arteries of asthma patients1.  Rydell-T 
Tormanen et al. also detected increased collagen in the intima of pulmonary 
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arteries in allergic mice5.  In PAH, extensive fibrosis of the arterial wall limits the 
vasodilatory capacity of the vessel, contributing to increased arterial pressure.   
 In the present study, neointimal formation was a component of arterial 
remodeling with chronic inflammation as evidenced by the presence of multiple 
layers of cells on the luminal side of the interna elastica.  In untreated mice, the 
intima was composed of the interna elastica and a single layer of thin endothelial 
cells that lined the arterial lumen.  In many remodeled vessels, the interna 
elastica was difficult to visualize.  This result may be due to the finding that 
elastase activity is increased during vessel remodeling, and elastase may 
participate in the remodeling process by degrading the elastic membranes8.  
Nonetheless, neointimal formation is a hallmark of severe pulmonary arterial 
hypertension7.  Collectively, the data presented in this study indicate that 
pulmonary arterial remodeling associated with the chronic inflammatory response 
to A. fumigatus was severe and shared many features with the arterial 
remodeling described in PAH. 
 In the absence of CD4+ T cells, pulmonary inflammation was attenuated 
and pulmonary arterial remodeling was significantly abrogated after chronic 
exposure to A. fumigatus conidia.  However, the arterial lumens were significantly 
narrowed in doubly anti-CD4 treated and conidia exposed mice compared to 
naïve, healthy mice as determined by morphometric analysis of randomly 
selected vessels.  Daley et al. demonstrated that arterial remodeling, as 
measured by a histological scoring system, was largely abolished in the absence 
of CD4+ T cells after chronic exposure to A. fumigatus antigens2.  The 
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discrepancy in detecting CD4+ T cell-independent remodeling may lie in 
differences between the innate responses to A. fumigatus conidia and antigen 
extracts.  Alternatively, the scoring system in the their study may not have 
reflected a degree of arterial lumen narrowing that was measured in our study by 
morphometry.  Nonetheless, these data imply that CD4+ T cell-mediated chronic 
inflammation contributes to the pathogenesis of pulmonary arterial remodeling. 
 In the present study, severe arterial remodeling associated with chronic 
allergic airway inflammation did not result in a significant increase in pulmonary 
arterial pressure or in right ventricular hypertrophy.  Daley et al. presented 
arterial histopathology that was very similar to that presented in the present 
study, and they also did not detect pulmonary arterial hypertension or right 
ventricular hypertrophy as a result2.  PAH is a complex disease involving genetic 
susceptibility, augmented vasoconstriction and arterial remodeling9.  It is possible 
that C57BL/6 mice lack a necessary genetic predilection for the development of 
pulmonary arterial hypertension.  Alternatively, it is possible that pulmonary 
hypertension did not develop in the present study because pathophysiological 
vasoconstriction was absent. 
 In conclusion, the chronic pulmonary hypersensitivity response to A. 
fumigatus promoted the pathogenesis of pulmonary arterial remodeling 
reminiscent of the histopathological appearance of the remodeled arteries seen 
in PAH.  PAH is a severe disease that leads to right heart failure and death, and 
there is no cure for PAH.  The pathogenesis of arterial remodeling in PAH is 
poorly understood, but mounting evidence suggests inflammation may play an 
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important role10. This study contributes to a growing recognition that inflammation 
associated with chronic AAD may represent a novel mechanism for pulmonary 
arterial remodeling.  However, this study is the first to demonstrate that 
pulmonary arterial remodeling can result from a natural route of exposure to a 
natural aeroallergen in its native form.  The physiologically relevant model for 
progressive pulmonary arterial remodeling described in this study provides future 
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Hypersensitivity Response to Aspergillus fumigatus:  The Roles of the 





 CD4+ T helper (TH) cells coordinate the adaptive immune response largely 
through the production of cytokines.  For this reason, various TH subsets are 
categorized by the cytokines they produce.  TH1 cells produce IFN , TH2 cells 
produce IL-4, IL-5, and IL-13, and TH17 cells produce IL-17.  Likewise, CD4
+ 
regulatory T cells (TReg) are recognized for the production of cytokines with anti-
inflammatory activity, including IL-10 and TGF .  TH cytokines are central to the 
promotion of particular adaptive immune response “programs” that likely 
developed evolutionarily to counter particular pathogenic threats.  As reported 
Chapters 3-6, repeated exposure to Aspergillus fumigatus conidia resulted in the 
pathogenesis of CD4+ T cell-dependent allergic airway disease (AAD) and 
pulmonary arterial remodeling.  The acute and chronic phases of the 




 During continued exposure to viable A. fumigatus conidia, the IL-4-
dependent TH2 immune response mediates the immunopathogenesis of allergic 
airway disease and pulmonary arterial remodeling, and both the IFN -dependent 
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TH1 response and the IL-10-dependent anti-inflammatory response antagonize 
the manifestation and outcome of the TH2 response.  
 
Objectives 
1. To determine the roles for IL-4, IFN , and IL-10 in the pathogenesis of 
allergic airway disease resulting from inhalation of viable A. fumigatus 
conidia. 
2. To determine the roles for IL-4, IFN , and IL-10 in the pathogenesis of 
pulmonary arterial remodeling resulting from inhalation of viable A. 
fumigatus conidia. 
3. To determine the necessity for IL-5 and, by extension, eosinophil 
involvement in the TH2-dependent immunopathogenesis of pulmonary 
arterial remodeling resulting from inhalation of viable A. fumigatus conidia. 
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RESULTS 
 To determine the role of critical CD4+ T cell cytokines in the CD4+ T cell-
dependent hypersensitivity response to A. fumigatus prominent features of the 
hypersensitivity disease were evaluated in IL-4, IFN , and IL-10 cytokine-
deficient mice.  Cellular inflammation was evaluated in wild-type and cytokine-
deficient mice at the peak of allergic airway response after four exposures to A. 
fumigatus conidia (Figure 7-1).  Compared to C57BL/6, the number of cells 
recovered from the airway by BAL was similar in IFN -/- mice, reduced by about 
two-fold in IL-4-/- mice, and slightly reduced in IL-10-/- mice.  As was the case for 
C57BL/6 mice, silver-stained histological lung sections indicated that A. 
fumigatus did not grow in the lungs of cytokine-deficient mice (see Appendix 2, 
Figure A2-11). 
 Airway leukocyte differential counts were performed on cells recovered by 
bronchoalveolar lavage (BAL) at the peak of allergic inflammation (Figure 7-2).  
Compared to C57BL/6 mice, the number of airway eosinophils was similar in 
IFN -/- mice and significantly reduced by about eight-fold in IL-4-/- and IL-10-/- 
mice.  There were only mild and not significant differences in the numbers of 
other leukocyte subsets present in the airway between wild-type and cytokine-
deficient mice.   
 As determined by flow cytometric analysis, the number of CD4+ T cells 
recovered from the airway by BAL was slightly increased in IFN -/- and IL-10-/- 
mice and slightly decreased in IL-4-/- mice, all in comparison to C57BL/6 mice 
(Figure 7-3).  The production of TH cytokines was examined in wild-type and 
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cytokine-deficient mice by flow cytometry after a brief period of in vitro stimulation 
(Figure 7-4).  Note that in previous studies, we detected cytokine production only 
in CD4+ T cells recovered from the effector site, the airway, and not from the 
draining lymph nodes or spleen (see Chapter 4).  The percent of CD4+ T cells 
producing IFN  in IL-4-/- mice and the percent of CD4+ T cells producing IL-4 in 
IFN -/- mice were essentially equal to those populations in C57BL/6 mice.  These 
data suggested that TH1 and TH2 did not counterregulate one another in wild-type 
mice through the production of IFN  and IL-4, respectively.  Interestingly, in IL-10-
/- mice the frequency of IFN -producing TH1 cells was similar to C57BL/6, but the 
frequency of IL-4-producing TH2 cells was significantly reduced by greater than 
four-fold compared to C57BL/6.  IL-10-/- mice develop spontaneous intestinal 
inflammation1, but the reduced TH2 response was detected in IL-10
-/- mice that 
did not exhibit overt colitis based on histological evaluation or increased serum 
TNF  levels measured by ELISA (see Appendix 2, Figure A2-12).  These data 
suggested that IL-10 contributed to the development of a TH2 response in wild-
type mice, or that in the absence of IL-10 a TH2-inhibitory mechanism, not active 
in wild-type mice, was activated. 
 Pulmonary arterial remodeling associated with chronic inflammation was 
evaluated in wild-type and cytokine-deficient mice after eight weekly exposures 
to A. fumigatus conidia (Figure 7-5).  In addition to IL-4-/-, IFN -/-, and IL-10-/- 
mice, IL-5-/- mice were included.  IL-5 is critical for the bone marrow development 
and tissue recruitment of eosinophils, and IL-5-/- mice developed TH2 cells but not 
airway eosinophilia (see Appendix 2, Figure A2-13).  After chronic exposure to A. 
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fumigatus, remodeled arteries were detected in C57BL/6, IFN -/-, and IL-5-/- mice 
but not in IL-4-/- and IL-10-/- mice.  So, arterial remodeling was associated only 
with those mice that developed a CD4+ TH2 cell response to A. fumigatus.   
 In order to quantify the extent of arterial lumen narrowing, morphometric 
analysis was employed (Figure 7-6).  Arteries were selected from the lungs in 
random fashion using an automated microscope apparatus.  The cross-sectional 
areas of the artery and the patent lumen were measured in a blinded fashion.  
C57BL/6 mice had significantly greater arterial lumen narrowing compared to IL-
4-/- and IL-10-/- mice, but not compared to IFN -/- and IL-5-/- mice.  Lumen patency 
in IL-4-/- and IL-10-/- mice after chronic exposure was similar to lumen patency in 
naïve wild-type mice as previously determined.  While IFN -/- mice exhibited 
severe remodeling, the proportion of affected vessels was slightly reduced 
compared to C57BL/6 or IL-5-/- mice, suggesting that IFN  was not required for, 
but may have contributed to, arterial remodeling.  In all likelihood, the type of 
inflammation and not just the extent of inflammation influenced these results, 
because whole lung and perivascular inflammation in IL-10-/- mice were 
comparable in extent to that seen in C57BL/6 mice (see Appendix 2, Figure A2-




Figure 7-1.  Fewer cells are recruited to the airway in the absence of IL-4, 
and to a lesser extent IL-10, after repeated inhalation of conidia. 
Mice were exposed to A. fumigatus four times on a weekly basis to induce the 
maximal allergic airway disease.  Cells were recovered by bronchoalveolar 
lavage and enumerated under a microscope with a hemacytometer.  Each 
cytokine-deficient mice group was included in three independent experiments 
along with a C57BL/6 control mice group.  The mean number of cells recovered 
from each cytokine-deficient mice group was normalized to the mean number of 
cells recovered from the control mice group in each particular experiment in order 
to address experiment to experiment variation in the extent of cellular 
inflammation.  This bar graph depicts the mean (+SEM) of the ratios generated 
from three independent experiments per group. 
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Figure 7-2.  Airway eosinophilia is significantly abrogated in mice lacking 
IL-4 or IL-10 in comparison to either C57BL/6 or IFN -deficient mice. 
Mice were exposed to A. fumigatus four times on a weekly basis to induce the 
maximal allergic airway disease.  Leukocyte differential analyses of airway cells 
were performed with flow cytometry, as described in Appendix 1.  The mean 
number of cells recovered from each cytokine-deficient mice group was 
normalized to the mean number of cells recovered from the control mice group in 
each particular experiment in order to address experiment to experiment 
variation in the extent of cellular inflammation.  This bar graph depicts the mean 
(+SEM) of the ratios generated for each leukocyte subset from three independent 
experiments per group.  *p < 0.01 compared to IFN -/-; p < 0.05 compared to 




Figure 7-3.  The absence of select cytokines results in slight differences in 
airway CD4+ T cell numbers. 
Mice were exposed to A. fumigatus four times on a weekly basis to induce the 
maximal allergic airway disease.  CD4+ T cells present in the airway cell 
population were identified by flow cytometric analyses.  The mean number of 
cells recovered from each cytokine-deficient mice group was normalized to the 
mean number of cells recovered from the control mice group in each particular 
experiment in order to address experiment to experiment variation in the extent 
of cellular inflammation.  This bar graph depicts the mean (+SEM) of the ratios 







Figure 7-4.  IL-4+ TH2 CD4
+ T cells were significantly diminished in IL-10-deficient 
mice. 
Mice were exposed to A. fumigatus four times on a weekly basis to induce the maximal 
allergic airway disease.  Airway cells were analyzed for cytokine production by flow 
cytometry, as detailed in the materials and methods.  Pooled cells for each group were 
briefly activated in vitro for 5h with PMA and ionomycin in the presence of monensin in 
order to enhance cytokine production and block its secretion, respectively.  A) Gated 
CD4+ lymphocytes were analyzed for the intracellular accumulation IFN  and IL-4 (see 
axes labels for density plots).  Quadrants were set with intracellular isotype control-
stained CD4+ lymphocytes (not shown) and the percentage of CD4+ lymphocytes in each 
quadrant is included on each plot.  B) The value determined for each cytokine-deficient 
mice group was normalized to the value determined for the control mice group in each 
particular experiment in order to address experiment to experiment variation.  This bar 
graph depicts the mean (+SEM) of the ratios generated from three independent 
experiments per group for the percent of CD4+ T cells positive for the particular cytokine.  




Figure 7-5.  Cytokine-deficient mice that do not develop a TH2 response to 
A. fumigatus do not exhibit arterial remodeling in the lung. 
To induce arterial remodeling in the lung, mice were exposed to A. fumigatus 
once a week for eight total exposures.  Histological sections of lung tissues were 
stained with H&E.  Representative photomicrographs include medium-sized 
muscular arteries adjacent to conducting airways.  Images depict the extent of 
arterial remodeling present in C57BL/6 and select cytokine-deficient mice.  Black 





Figure 7-6.  Significant arterial wall thickening is absent from cytokine-
deficient mice that do not develop a TH2 response to A. fumigatus. 
To induce arterial remodeling in the lung, mice were exposed to A. fumigatus 
once a week for eight total exposures.  In order to quantify the extent of arterial 
lumen narrowing, morphometric analyses were performed on histological 
sections of lung tissues from C57BL/6 and select cytokine-deficient mice.  An 
automated set-up was used to select random fields of the left lung from each 
sample and all muscular arteries obtained were measured, as described in the 
methods.  The data are presented as the cross-sectional area of the lumen 
divided by the total cross-sectional area of the vessel for all vessels with a 
length-to-width ratio less-than-or-equal-to 2.5, thereby excluding tangential artery 
sections.  Also, very small and large arteries were excluded, as explained in the 
methods.  For each cytokine-deficient mice group, data were collected from at 
least two independent experiments including C57BL/6 controls, and at least six 
mice total per group were analyzed.  Each artery is represented by a symbol on 
the scatter plot, and the mean for each group is indicated by a horizontal line.  
Arteries from untreated C57BL/6 were measured in a previous study (n=38 
arteries from 8 mice), and the mean and the 25th and 75th quartiles from that 
study are included for reference (dashed and solid lines and grey bar).  
Significant differences between groups are labeled on the plot. 
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DISCUSSION  
 The data presented in this chapter demonstrated that IL-4 and IL-10 were 
critical to the immunopathogenesis of both an AAD and pulmonary arterial 
remodeling that resulted from repeated inhalation of viable Aspergillus fumigatus 
conidia.  In IL-4-/- and IL-10-/- mice, CD4+ TH2 cell responses were significantly 
reduced compared to C57BL/6 and IFN -/- mice.  These date were consistent 
with a critical role for TH2 cells in mediating the immunopathogenesis of AAD and 
pulmonary arterial remodeling. 
 The TH2 immune response to inhaled A. fumigatus conidia was not 
affected by the presence or absence of IFN , a critical TH1 cytokine.  During the 
acute inflammatory phase in the present study, airway eosinophilia was greatly 
reduced in IL-4-/- compared to C57BL/6 mice, but airway eosinophilia was similar 
in IFN -/- and C57BL/6 mice.   Also, the frequency of IL-4-producing TH2 cells 
within the airway CD4+ T cell population was similar in IFN -/- and C57BL/6 mice, 
and the frequency of IFN -producing TH1 cells in the airway CD4
+ T cell 
population was similar in C57BL/6 and IL-4-/- mice.  Due to a number of 
conflicting reports, further clarification of the impact of TH1 cells on TH2-mediated 
AAD is necessitated. In rodent models of allergic airway disease, TH1 cells were 
reported to inhibit the ability of TH2 cells to promote allergic disease in an IFN -
dependent manner2, 3.  Airway administration of IFN  or IL-12, a TH1-promoting 
cytokine, also diminished the manifestations of TH2-mediated allergic airway 
responses4, 5.  However, other research studies indicated that TH1 cells 
augmented airway inflammation in cooperation with allergy-inducing TH2 cells
6, 7. 
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Data produced in the present study suggested that TH2 and TH1 priming were 
independent events, and that a TH1/TH2 counterregulatory mechanism was not 
active.   
 In the present study, the TH2 cell response in mice possessing a genetic 
deficiency for IL-10 was significantly attenuated compared to IL-10-sufficient 
control mice.  On the other hand, the airway TH1 cell response was similar in IL-
10-/- and C57BL/6 mice.  The principle role of IL-10 is to limit and ultimately 
terminate inflammatory responses8.  In an animal model of AAD, IL-10 gene 
transfer to the airway suppressed the development of allergic airway 
sensitization9.  In previous reports on the immune response to A. fumigatus, IL-
10-/- mice developed an exaggerated TH1 response to viable conidia
10, and the 
allergic response to antigen extracts was similar in IL-10-/- and wild-type mice11.  
Disparities between the preparation, dose, and frequency of A. fumigatus used in 
those studies and the present one may explain the different findings.  Similar to 
the present study, other reports described the attenuation of TH2 responses in IL-
10-deficient mice.  Those studies included investigations of a pulmonary infection 
with the fungus Cryptococcus neoformans12, an OVA sensitization and challenge 
model of AAD13, and a murine model of allergic dermatitis14.  Clearly, IL-10 is a 
pleiotropic cytokine that has immunomodulatory and anti-inflammatory 
properties.  The requirement for IL-10 in the development of TH2 responses in 
certain settings, such as that described in the present study, necessitates further 
investigation into this functional capacity of IL-10.  
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 In the present study, arterial remodeling did not develop in those mice that 
did not mount a TH2 response to A. fumigatus.  Severe arterial remodeling was 
detected in C57BL/6 and IFN -/- mice, but not in IL-4-/- and IL-10-/- mice.  Recent 
studies have reported that prolonged allergic inflammation in the lung resulted in 
arterial remodeling, suggesting a possible pathogenic role for chronic TH2-
mediated inflammation in the process15, 16.  Daley et al. demonstrated that arterial 
remodeling associated with AAD was significantly abrogated in the absence of 
CD4+ T cells, in IL-4-deficient mice, and in mice treated with an IL-13 blockade 
reagent15.  Our study confirmed the role of CD4+ T cells (see Chapter 6) and IL-4 
in the pathogenesis of arterial remodeling in the context of chronic AAD.  The 
critical role of TH2 cells in arterial remodeling was further supported by data 
presented here from the study of IL-10-/- mice.  Compared to C57BL/6 mice, IL-
10-/- mice had significantly attenuated levels of pulmonary arterial remodeling and 
TH2 cells, but IL-10
-/- mice had comparable levels of pulmonary inflammation, TH1 
cells, and TH17 cells (see this Chapter and Appendix 2, Figures A2-14 and 15).   
Finally, the present study indicated that IL-5, and by extension eosinophils (see 
Appendix 2, Figure A2-13)17, were not a critical component of the TH2 response 
that promoted arterial remodeling.  These data strongly support a pathogenic role 
for TH2-mediated inflammation in the development of pulmonary arterial 
remodeling.  
 In conclusion, the study of cytokine-deficient mice elucidated the critical 
role of the TH2 immune response for the immunopathogenesis of AAD and 
pulmonary arterial remodeling in the context of a hypersensitivity response to A. 
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fumigatus.  The contribution of IL-10 was required for the development of TH2 
cells in this study, illustrating an underappreciated regulatory function of this 
pleiotropic cytokine. Along with several recent reports, the data presented in this 
study provide evidence for a novel mechanism whereby chronic TH2-mediated 
allergic pulmonary inflammation induces arterial remodeling.  These observations 
should stimulate further investigation into the immunopathogenesis of AAD and 
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 In this study, repeated inhalation of viable A. fumigatus conidia resulted in 
a hypersensitivity response after several weeks of exposure.  Twenty-four hours 
after the first exposure an innate immune response appeared, characterized by 
the production of TNF  and the recruitment of neutrophils.  In the absence of 
fungal growth, the magnitude of the inflammatory response increased 
significantly after the third exposure, 15 days after the initial exposure, and many 
prototypical features of an allergic airway response were evident.  These features 
included the presence of peribronchial and peribronchiolar cellular infiltrates, 
significant airway eosinophilia, the presence of TH2 cytokines in the airway, the 
increased production of IgE, and goblet cell metaplasia with mucus 
hypersecretion.  In spite of the characteristic allergic airway disease (AAD), the 
mice exposed repeatedly to A. fumigatus did not exhibit increased airway 
hyperreactivity (AHR).   
 Coincident with the onset of the AAD, the number of CD4+ T cells in the 
airway increased significantly.  Activated, cytokine-producing effector CD4+ TH 
cells were present in the airway, but they were not detected in the draining lymph 
nodes or spleen.  In the absence of CD4 + T cells, the allergic airway response 
was severly attenuated, including airway eosinophilia and BALF TH2 cytokine 
levels.  However, the innate immune response remained intact, as evidenced by 
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neutrophil recruitment and TNF  secretion, and A. fumigatus did not grow in the 
lungs.  The adoptive transfer of A. fumigatus-primed, but not naïve, CD4+ T cells 
augmented the development of the AAD.   
 Pulmonary inflammation persisted with chronic exposure to viable 
Aspergillus fumigatus conidia.  Several parameters of the AAD were similar in 
severity during the acute and chronic inflammatory phases, including the number 
of leukocytes present in the airways, the level of serum total IgE, and the 
presence of mucus hyperproduction.  While the total number of CD4+ T cells in 
the airways was similar at both time points, the proportions of CD4+ TH subsets 
were not static.  After four exposures to conidia, the frequencies of cytokine-
producing TH1, TH2, and TH17 cells (~10-15% of total CD4
+ T cells) were roughly 
equivalent.  However, after eight exposures, the frequency of TH17 cells was 
significantly increased, and the frequency of TH2 cells was moderately 
decreased.  Goblet cell metaplasia and mild peribronchial fibrosis were detected 
at both time points, but remodeling was not progressive.  In spite of persistent 
inflammation, chronic exposure to A. fumigatus conidia did not result in increased 
AHR.   
 The chronic hypersensitivity response to Aspergillus fumigatus did result 
in severe remodeling of pulmonary arteries and in significant narrowing of arterial 
lumens. The remodeled arterial walls were muscularized, fibrotic, and 
accompanied by signs of neointimal formation.  CD4+ T cells were required for 
the full manifestation of pulmonary inflammation and arterial remodeling.  Though 
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mice developed severe arterial muscularization, arterial fibrosis, and significant 
luminal narrowing, mice did not develop pulmonary hypertension as a result.   
 In IL-4-/- and IL-10-/- mice, CD4+ TH2 cell responses were significantly 
reduced compared to C57BL/6 and IFN -/- mice.  IL-4-/- and IL-10-/- mice did not 
exhibit acute airway eosinophilia or chronic pulmonary arterial remodeling.  Like 
C57BL/6 mice, IFN -/- and IL-5-/- mice did develop remodeled arteries, but 




 CD4+ TH2 cells were primed by respiratory exposure to A. fumigatus 
conidia and mediated an allergic hypersensitivity response to A. fumigatus 
conidia upon re-exposure.  Therefore, this study introduces a novel, 
physiologically relevant murine model for the study of allergic airway disease.  
Prolonged exposure to A. fumigatus conidia resulted in chronic CD4+ TH2 cell 
activity that coordinated the pathogenic remodeling of pulmonary arteries.  The 
TH2-mediated pathogenesis of arterial remodeling did not require eosinophils, 
and a component of the pathogenic response was CD4+ T cell-independent.  
These data support and further an emerging, novel pathway for the pathogenesis 
of pulmonary arterial remodeling, the primary abnormality in pulmonary arterial 
hypertension, a severe and poorly understood human disease.  IL-10 was 
required to support the IL-4-dependent induction of the allergic TH2 response.  
This is further evidence of a role for IL-10 in the induction of TH2 immunity 
separate from the well-defined anti-inflammatory role of IL-10.  A TH17 response 
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was positively correlated with continued exposure to A. fumigatus conidia, but the 
TH17 response did not mediate pulmonary arterial remodeling in the absence of a 
TH2 response.  These data advance the nascent understanding of the 
physiological role(s) of TH17 cells.   
 
Critical Review 
 In all likelihood, the dose and frequency of exposure to viable A. fumigatus 
conidia utilized in this study had a major impact on the strength and character of 
the inflammatory response.  Therefore, the data presented are representative of 
the response to this dose and frequency of conidia, and should not be 
generalized to A. fumigatus without regard to this fact. 
 Due in large part to the complex nature of this living, eukaryotic allergen, 
antigen-specific adaptive immune responses were not measured in this study. 
The growth of the fungus in cultures generated from conidia-exposed tissues 
hampered in vitro studies, although voriconazole was not used in this study and 
is reported to prevent fungal growth1.  Commercially available A. fumigatus 
antigens induced low or undetectable levels of cytokines in co-culture 
experiments with secondary lymphoid tissues, and serum antibody levels were 
low to undetectable when measured against the antigens.  Because purified 
antigens were produced from a growing fungal mycelium, it is possible that the 
purified antigens did not contain high concentrations of the antigens that 
provoked a response after inhalation of conidia in vivo.   
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 In spite of the presence of multiple features of AAD, mice repeatedly 
exposed to conidia did not exhibit a significant increase in airway hyperreactivity 
(AHR). While mice do not develop a breathing disorder similar to asthma, 
increased airway resistance is often demonstrated by methacholine challenge2.  
The strain of mouse used in this study, C57BL/6, is widely recognized as a low-
responder strain for the manifestation of AHR3-5.  The utility of this model of AAD 
for studies on the development and treatment of AHR would be enhanced by a 
demonstration of increased AHR in a more susceptible strain of mice. 
 In the present study, silver-stained histological lung sections did not reveal 
morphological evidence of A. fumigatus hyphae in the remodeled arteries though 
background staining was increased (see Appendix 2, Figure A2-10).  A. 
fumigatus hyphae have a marked tropism for blood vessels, and angioinvasion is 
a component of invasive aspergillosis seen in immunocompromised individuals6.  
Angioinvasion results in endothelial cell injury, thrombosis, and tissue infarction7.  
Endothelial cell injury and thrombosis are also features of arterial remodeling in 
PAH8.  However, we never found any evidence of an infectious outcome resulting 
from repeated exposure to viable conidia.  Therefore, it cannot be entirely 
discounted that the tropism for blood vessels attributed to A. fumigatus was 
involved in the pathogenesis of arterial remodeling, but angioinvasion likely was 
not involved. 
 Severe pulmonary arterial remodeling did not result in an elevation of 
pulmonary arterial pressure.  Increased pulmonary arterial pressure has been 
measured in murine models of pulmonary arterial hypertension resulting from 
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chronic hypoxia or genetic modification9-11.  Hypoxia and germline mutations 
affect the entire lung in a uniform manner.  In the present study, many arteries 
were completely occluded and arterial involvement throughout the lung was 
extensive.  Nonetheless, inflammation and arterial remodeling throughout the 
lung was not uniformly distributed, and irregularities in the vascular involvement 
may have prevented an increase in pressure for the whole system.  It is also 
possible that remodeling did not involve critical regions along the vascular tree 
that promote pulmonary arterial hypertension.  In a study of pulmonary arterial 
remodeling in response to chronic hypoxia, the authors concluded that increased 
vascular resistance was due to small artery muscularization and decreased 
vascular impedance was due to proximal artery fibrosis12.  Finally, it is possible 
that the pathological process in the present study did not involve additional 
mediators that promote vasoconstriction or limit vasodilation. 
 
Future Directions 
• The mechanism of CD4+ TH2 cell development in response to in vivo 
exposure to a respiratory allergen could be further examined in this model.  
Several transgenic mice were described that would be particularly useful 
for this study.  In 2001, the Locksley group engineered mice to express 
enhanced green fluorescent (EGFP) protein linked to IL-4, so all IL-4-
producing cells were detectable by the fluorescent marker13.  These mice 
were proven extremely useful in studies on the role of IL-4 in TH2 and 
allergic responses14-22.  In 2006, A. fumigatus-specific, CD4+ TCR-
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transgenic mice were developed by the Pamer group.  In response to a 
single intranasal dose of 1 107 viable conidia, A. fumigatus-specific CD4+ 
TH1, but not TH2, cells were primed locally.  These transgenic mice would 
be useful in the examination of the development of the CD4+ TH2 cell 
response described in this study.  Alternatively, MHC-antigen-tetramer 
reagents also would be useful to follow the responding CD4+ T cells. 
 
• The mechanism by which IL-17 mediates pathological inflammation is not 
well understood23.  IL-17 promotes the recruitment of neutrophils24, and 
anti-IL-17 treatment simultaneously abrogated neutrophil recruitment and 
enhanced IL-5 production and eosinophil recruitment, in a model of AAD25.  
In the present study, chronic inflammation also was associated with a 
decline in TH2 responses and pulmonary arterial remodeling.  IL-23 
sustains chronic TH17 inflammatory responses, and IL-23 is composed of 
a unique p19 subunit and a p40 subunit that is shared with IL-1226.  While 
IL-23 is not necessary for the development of TH17 cells, IL-23-deficient 
(p19-/-) mice exhibited attenuated TH17 responses
27.  These mutant mice 
would be useful for an investigation of the role of TH17 cells in the AAD to 
A. fumigatus conidia.  Additionally, in vivo IL-17 neutralization with anti-IL-
17 antibody would complement the use of IL-23p19-/- mice28.  A potential 
pitfall of this study would be if IL-17 reduction prevents neutrophil 
recruitment leading to a pulmonary infection with A. fumigatus.  In this 
event, A. fumigatus antigens, which also promoted pulmonary arterial 
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remodeling in a chronic AAD model, would be substituted for viable 
conidia. 
 
• Noverr et al. demonstrated that disruptions in the gastrointestinal 
microbiota influenced the allergic response to A. fumigatus conidia29, 30.  
IL-10-/- mice develop colitis that is dependent of the presence of the 
microbiota and is associated with enhanced production of IL-12 and IL-
2331, 32.  Selective production of IL-12 and IL-23 by antigen presenting 
cells (APC) may result in promotion of TH1 and TH17 responses at the 
expense of the TH2 response.  Experiments would test the possibility that 
spontaneous colitis and/or IL-12 and/or IL-23 prevented the development 
of the TH2 response to A. fumigatus conidia.  Broad spectrum antibiotic 
treatment limited colitis33, and would be used to inhibiting colitis in IL-10-/- 
mice.  Anti-IL-12p35, anti-IL-23p19, or anti-IL-12p40 antibodies would be 
used in IL-10-/- mice to block IL-12, IL-23, or both, respectively.  Different 
combinations of antibiotic and antibody treatments would reveal TH2 
limiting factors that may be some combination of colitis, IL-12, and IL-23.  
Negative results would indicate the IL-10 works through some other direct 
or indirect mechanism to support the development of CD4+ TH2 cells in 
this model. 
 
• Alternatively-activated macrophages (AAM ) are polarized during TH2 
immune responses by IL-4 or IL-13, and AAM  promote cell proliferation 
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and collagen deposition, two likely features of arterial remodeling in the 
present study34.  In 2004, the Brombacher group developed 
macrophage/neutrophil-specific IL-4 receptor alpha-deficient mice and 
demonstrated that AAM  did not develop in these mice during prototypical 
TH2 responses
35.  These mice would be useful for testing the hypothesis 
that AAM  are mediators of pathologic TH2-driven arterial remodeling.  A 
potential drawback to this approach is that unopposed TH1 cytokine 
polarization of classically-activated macrophages may result in 
unexpectedly severe pulmonary inflammation.  A well-controlled study with 
the addition of anti-IFN  antibody might address this issue. 
 
• In PAH patients, one study reported increased frequencies of certain 
polymorphisms in the fractalkine receptor, CX3CR1
36, and another study 
reported increased levels of fractalkine and CX3CR1
+ leukocytes37.  Unlike 
other chemokines, endothelial cell-anchored fractalkine can mediate rapid 
and firm adhesion to CX3CR1-expressing cells under high blood flow
38.  A 
recent study identified a novel patrolling behavior of blood monocytes, 
whereby Gr1- monocytes exhibited long-range crawling interactions with 
healthy endothelium, including that of arteries, and CX3CR1-dependent 
extravasation in response to endothelial damage and tissue 
inflammation39.  Interestingly, recently recruited CX3CR1
+ monocytes 
rapidly differentiated into M  expressing genes associated with the AAM  
phenotype39.  During the acute inflammatory response to A. fumigatus 
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conidia, we detected the intravascular accumulation of cells with a 
leukocyte appearance that preceded arterial remodeling.  Anti-CX3CR1 
neutralizing antibody, administered during the period of respiratory 
exposure to conidia, would be used to test the role of fractalkine-CX3CR1 
interactions in mediating pulmonary arterial remodeling, after preliminary 
experiments detected the accumulation of CX3CR1
+ monocytes in the 
arteries.  If the intravascular cells were not identified as CX3CR1
+ 
monocytes, laser-capture microscopy would be used to isolate the cells of 
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In this dissertation, I tested the following hypotheses: 
1. Pulmonary hypersensitivity disease will result from repeated inhalation of 
viable A. fumigatus conidia, a natural aeroallergen in its native form. 
2. CD4+ T cells mediate the hypersensitivity response to inhaled viable A. 
fumigatus conidia upon re-exposure. 
3. Due to the inherent allergenicity of viable A. fumigatus conidia, chronic 
exposure will result in progressive pathophysiological alterations to the 
lungs. 
4. Immunopathological alterations in pulmonary arterial anatomy and 
physiology will result from chronic inflammation in the lung promoted by 
repeated, weekly inhalation of viable A. fumigatus conidia. 
5. During continued exposure to viable A. fumigatus conidia, the IL-4-
dependent TH2 immune response mediates the immunopathogenesis of 
allergic airway disease and pulmonary arterial remodeling, and both the 
IFN -dependent TH1 response and the IL-10-dependent anti-inflammatory 
response antagonize the manifestation and outcome of the TH2 response. 
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I conclude that the research presented in this dissertation producing the following 
significant contributions to the field: 
• This study introduced a unique, physiologically relevant model of AAD.  
Inhalation of A. fumigatus conidia, a natural aeroallergen ubiquitous in the 
environment, promoted a CD4+ TH2 cell mediated AAD.  Sensitization to 
this natural aeroallergen was achieved through a natural route of exposure 
by repeated inhalation without any form of systemic sensitization.  In the 
absence of fungal growth or accumulation detected by silver-stained 
histological sections of lung, the allergic response developed after 3 
exposures, appearing 15 days after the initial exposure.  Prototypical 
features of AAD that were increased included airway IL-4-producing TH2 
cells, airway TH2 cytokine levels, airway eosinophils, serum total IgE, and 
goblet cell metaplasia with mucus hyperproduction.  Previous reports 
documented other AAD disease models that featured repeated respiratory 
exposure to natural allergens, including A. fumigatus antigen extracts, 
ragweed antigen extracts and house dust mite (HDM) antigen extracts, in 
previously unsensitized mice1-4.  In spite of a robust AAD, mice exposed 
repeatedly to conidia did not develop increased airway hyperreactivity in 
the present study, in contrast to the models that relied on antigen extracts 
mentioned above.  In terms of A. fumigatus, conidia represent the likeliest 
form of the fungus encountered in the environment.  
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• This study provided novel insight into the mechanism by which respiratory 
antigens promote the differentiation of CD4+ TH2 cells.  Activated, IL-4-
producing effector CD4+ TH2 cells, implicated in the allergic response to 
inhaled conidia, were found exclusively in the airway and not in the lung-
draining lymph nodes or spleen.  IL-4 is a critical cytokine for the 
differentiation of CD4+ TH2 cells and the promotion of B cell class 
switching to IgE5, 6.  The source of IL-4 in the priming of CD4+ TH2 cells is 
an area of debate, because dendritic cells do not produce IL-4 
themselves7.  Furthermore, the location of CD4+ TH2 cell priming in atopic 
disease remains to be elucidated7.  TH2 cytokines were produced in the 
lung and secondary lymphoid tissue by CD4+ TH2 cells that were primed in 
vitro and transferred to naïve mice that were subsequently challenged with 
antigen8.  Interestingly, other studies demonstrated that CD4+ TH2 cell 
priming occurred in the lung in the absence of lymph nodes9-11.  The 
pattern of CD4+ TH2 cell activation and effector function acquisition in the 
present study was similar to the pattern observed for CD4+ TH1 cells in 
response to respiratory fungal infection with A. fumigatus or Cryptococcus 
neoformans12, 13.   
  
• This study contributed novel information regarding the potential role of 
CD4+ TH17 cells in chronic pulmonary hypersensitivity diseases.  CD4
+ 
TH17 cells were significantly increased during the transition from the acute 
to the chronic inflammatory response to A. fumigatus conidia.  CD4+ TH17 
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cells are a recently recognized subset of CD4+ TH cells that are implicated 
in chronic inflammation, particularly in autoimmunity14, 15.  A single 
inhalational challenge with A. fumigatus conidia or Candida albicans 
induced IL-17 production, and IL-17 promoted inflammation and negatively 
impacted the IFN -mediated host defense response to the fungi16, 17. 
 
• This study provided evidence that the pathogenesis of respiratory allergies 
may be aided by IL-10, a cytokine heralded as a therapeutic option to 
inhibit allergic inflammation.  The TH2-mediated AAD was abrogated in IL-
10-/- compared to C57BL/6 mice after repeated exposure to conidia.  The 
absence of IL-10 resulted in diminished airway IL-4-producing CD4+ TH2 
cells, airway eosinophils, and pulmonary arterial remodeling.  On the other 
hand, IL-10-/- and C57BL/6 mice were similar in terms of the frequency of 
airway IFN -producing CD4+ TH1 cells, the frequency of airway IL-17-
producing TH17 cells (Appendix 2), and the overall extent of pulmonary 
inflammation.  IL-10 is widely recognized as an anti-inflammatory cytokine 
that acts on most hematopoietic cells18.  Forced expression of IL-10 in the 
airway suppressed the development of allergic airway sensitization19, and 
IL-10-producing CD4+ TReg cells are regarded to possess 
immunotherapeutic potential for the treatment of allergic diseases20.  In 
addition to the present study, other reports indicated that the absence of 




• This study provided evidence to support a novel pathway for the 
pathogenesis of pulmonary arterial remodeling.  Severe fibromuscular 
remodeling of small-to-medium-sized pulmonary arteries developed as a 
result of chronic exposure to a respiratory allergen.  The arterial lumens 
were significantly narrowed and often fully occluded.  The arterial walls 
with greatly thickened by hyperplasia of -smooth muscle actin-staining 
cells and stiffened by extensive fibrosis.  Neointimal formation was 
evident.  The pathology of the remodeled arteries was very similar to the 
description of arterial remodeling associated with pulmonary arterial 
hypertension (PAH)24.  Currently, allergic hypersensitivity disease is not 
recognized for an association with PAH, but recent evidence indicates that 
chronic inflammation likely contributes to the pathogenesis of arterial 
remodeling in PAH25.  Earlier this year, Daley et al. published the first 
report to demonstrate that pulmonary artery muscularization developed 
with an inflammatory response to inhaled antigen26.  Intraperitoneal 
sensitization followed by ~4 weeks of intranasal challenge with A. 
fumigatus antigens yielded arterial pathology very similar to that presented 
in this study, as analyzed in H&E and -smooth muscle actin-stained 
tissue sections.  In the current study, we provided further evidence of 
neointimal development and arterial wall fibrosis, and we provided 
morphometric analysis of arterial lumen narrowing.   
o This study demonstrated that arterial modeling was mediated, at 
least in part, by CD4+ TH2 cell-mediated immunity.  Arterial 
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remodeling was partially abrogated in the absence of CD4+ T cells 
throughout the period of exposure to conidia.  The absence of 
arterial remodeling in IL-4-/- or IL-10-/- mice, strongly implicated a 
pathological role for the TH2-mediated response.  Finally, we 
showed that IL-5, and by extension eosinophils, were not a 
necessary component of the immunopathological TH2 response.  
Daley et al. also demonstrated the requirement for TH2-mediated 
inflammation based on data collected in the absence of CD4+ T 
cells, IL-4, and IL-13 signaling.  Collectively, these data provide 
strong evidence for a novel immunopathological mechanism for 
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 The severity and character of airway inflammation is analyzed frequently 
by leukocyte differential analysis of cells recovered by bronchoalveolar lavage 
(BAL).  Commonly, cells are affixed to glass sides by cytospin, treated with a 
cytological stain, and analyzed under a microscope.  However, differentiation of 
monocytes from activated lymphocytes and eosinophils from neutrophils can be 
problematic, and variability between experimenters can introduce 
inconsistencies.  In this study, we aimed to develop a simple, two-color flow 
cytometric leukocyte differential analysis for cells recovered from the airway by 
BAL.  Our goal was to differentiate the four main leukocyte populations:  
macrophages, neutrophils, lymphocytes, and eosinophils.  This method will allow 
for the consistent analysis of large numbers of cells to gauge the severity and 
character of airway inflammation.   
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RESULTS 
 A simple, two-color flow cytometric method for leukocyte differential 
analysis of cells recovered from the airway by BAL is described in this section.  
Several combinations of cell surface markers were tested in a series of 
experiments.  Differential expression of CD11c and Gr1 (Ly6-G/C) in addition to 
differences in the forward-scatter (FSC) and side-scatter (SSC) profiles allowed 
for the resolution of the four main leukocyte subsets:  macrophages, neutrophils, 
lymphocytes, and eosinophils. 
 Preliminary studies indicated that cells from all four main leukocyte 
subsets were found in the airway after several weekly exposures to Aspergillus 
fumigatus.  Differential expression of CD11c and Gr1 resulted in the resolution of 
four distinct populations of airway cells (Figure A1-1).  Staining with isotype 
control antibodies illustrated the range of autofluorescence exhibited by all the 
cells from the airway.  The vast majority of the autofluorescenthigh cells stained for 
the expression of CD11c.  It is firmly established that autofluorescenthigh cells 
recovered from the airway are macrophages1.  A population of Gr1high cells was 
separated from the remaining CD11c- population.  Gr1high cells are predominantly 
neutrophils2.  After the separation of the CD11c+ population and the Gr1high 
population, two distinct populations remained:  an autofluorescentlow, CD11c-Gr1- 
population, and an autofluorescentint, CD11c-Gr1low-int population.  The latter two 
populations did overlap to a slight degree on the CD11c vs. Gr1 plot. 
 Definitive identification of the leukocyte subsets was guided by three 
consecutive flow cytometric cell sorting experiments.  BAL cells from mice 
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exposed several times to A. fumigatus conidia were stained for CD11c and Gr1 
and purified by FACS.  Purified cells were affixed to glass slides by cytospin, 
stained with a modified Wright-Giemsa, and analyzed by standard cytological 
criteria.  The results are summarized in the remainder of this section.  CD11c+ 
leukocytes were FSCint-highSSCint-high, and these cells were predominantly 
macrophages (Figure A1-2ii, iii, and iv).  Gr1high leukocytes included three 
populations of cells ranging from FSClowSSClow-int to FSCintSSCint.  All three 
populations of Gr1high cells were predominantly neutrophils, and there were not 
obvious morphological differences between the three populations (Figure A1-2ii, 
vii, viii, xi, and xii).  CD11c-Gr1- leukocytes were FSClowSSClow, and these cells 
were predominantly lymphocytes (Figure A1-2ii, v, and ix).  CD11clowGr1low-int 
leukocytes were FSClowSSCint-high, and these cells were predominantly 
eosinophils (Figure A1-2ii, vi, and x).  Sorted cells were greater than 90% pure, 
indicating that this method was useful for performing a leukocyte differential 
analysis. 
 Based on the validating results of the cell sorting experiments, 
macrophages and neutrophils were routinely identified solely by the expression 
of CD11c and Gr1 (Figure A1-3).  As mentioned above, lymphocytes and 
eosinophils overlapped slightly on the CD11c vs. Gr1 plot.  However, 
lymphocytes and eosinophils were fully separated by FSC vs. SSC analysis, 
because lymphocytes were SSClow and eosinophils were SSCint-high.  Therefore, 
lymphocytes and eosinophils were routinely identified by the combination of FSC 
vs. SSC profiles and CD11c vs. Gr1 expression (Figure A1-3). 
 173 
 Other cell surface markers, besides CD11c and Gr1, were employed to 
analyze the leukocyte populations.  The following cell surface markers were 
chosen based on reports from other investigations:  F4/80, CD11b, Siglec F, and 
CCR3.  Low-level expression of F4/80 was detected in macrophage and 
eosinophil populations.  Low-level expression of CD11b was detected on small 
percentages of cells in the macrophage and lymphocyte population.  In contrast, 
neutrophils and eosinophils uniformly expressed a high level of CD11b.  High-
level expression of Siglec F was detected on eosinophils.  Macrophage and 
neutrophil populations expressed Siglec F as well, but the fluorescent shift was 
not as great.  The eosinophil population uniformly expressed CCR3, and minor 
expression of CCR3 was detected among the other subsets. 
 IL-5 is critical for the development and recruitment of eosinophils3.  After 
several exposures to A. fumigatus conidia, BAL cells from C57BL/6 and IL-5-/- 
mice were analyzed by the flow cytometric leukocyte differential analysis method 
described in this section in order to verify the correct identification of the 
neutrophil and eosinophil granulocyte populations.  Eosinophils and neutrophils 
were identified in C57BL/6 mice.  In IL-5-/- mice, the neutrophils were present, but 




Figure A1-1.  Staining of cells recovered from the airways with CD11c and 
Gr1 allows for the resolution of four discrete subsets. 
As described in the methods, leukocytes were recovered from the airways by 
bronchoalveolar lavage after several weekly exposures to A. fumigatus and 
analyzed by flow cytometry.  Cells were stained with isotype control antibodies, 




Figure A1-2.  CD11c and Gr1 expression distinguishes the four major leukocyte subsets. 
Flow cytometric cell sorting was employed to validate a method for the leukocyte differential 
analysis of cells recovered from the airway.  Cells were distinguished based on the expression of 
CD11c and Gr1and the forward- and side-scatter profile.  The strategy for identifying each 
population was developed during three successive sorting experiments, and a representation of 
the final experiment is presented here.  Based on data from preliminary studies, cells were pooled 
from mice exposed to A. fumigatus a variable number of times in order generate a population of 
total cells composed of relatively similar frequencies of each leukocyte subset.  The forward- and 
side-scatter profile and the CD11c and Gr1 expression pattern of the total cells population is 
shown (i and ii).  Cells were separated into four main populations based on the expression of 
CD11c and Gr1, and conservative gates were drawn around the central densities of each 
population (ii).  The forward- and side-scatter profiles of each gated population was examined 
(follow dashed arrows from ii to iii, v, vi, and vii; compare to the total cells population in i).  For 
three of the gated populations, the forward- and side-scatter profiles revealed essentially a single 
population of cells (iii, v, and vi).  The forward- and side-scatter profile of the fourth population 
revealed three distinguishable populations (vii).  Cells were sorted based on primary (ii) and 
secondary (iii, v, vi, and vii) gates as indicated by the dashed arrows.  Sorted cells were later 
affixed to glass slides and stained with a modified Wright-Giemsa.  Representative 
photomicrographs are shown (iv, viii-xii).  All photomicrographs are shown at the same scale and 
the black bar is 20μm in length (xii).  The purity of each sorted population was determined by 
evaluation of the cells under a microscope using standard morphological criteria.  The purity of 
each population sorted by this strategy was greater than 90%.  The population identities are 
labeled on the density plots of the primary gated cells (iii, v, vi, and vii).  (Note:  The three 




Figure A1-3.  The examination of additional cell surface molecules confirms 
the utility of the CD11c/Gr1 combination for airway leukocyte differential 
analysis. 
As previously described, a flow cytometric method was established for 
performing a leukocyte differential analysis on cells recovered from the airway.  
In practice, leukocyte subsets were identified as shown here.  Macrophages and 
neutrophils were separated by their expression of CD11c and Gr1 (top density 
plot in “leukocyte gates” column; follow dashed arrows).  Lymphocytes and 
eosinophils overlapped to a small extent based on their CD11c and Gr1 
expression, but they do not overlap based on their forward- and side-scatter 
profiles.  Therefore, lymphocytes and eosinophils were enriched independently 
with gates based on forward- and side-scatter (“enrichment gates” density plot; 
follow dashed arrows), and then identified from within the enriched population 
based on their expression of CD11c and Gr1 (middle and bottom density plots in 
“leukocyte gates” column; follow dashed arrows).  Each leukocyte population was 
evaluated further for their expression of certain surface markers of interest in a 
third fluorescent channel.  The leukocyte subset is labeled to the left of each row 
of histograms, and the surface marker is labeled on the x-axes for each column 
of histograms.  Background staining with isotype control antibodies is shown on 
each plot by the shaded histogram.  Data from one of two representative 




Figure A1-4.  The flow cytometric method for leukocyte differential analysis 
correctly discriminates between the granulocyte populations. 
IL-5-deficient mice were employed to verify further the correct identification of 
granulocytes using the flow cytometric method for leukocyte differential analysis 
previously described.  Mice were exposed to A. fumigatus several times to 
induce the characteristic allergic airways disease.  A granulocyte gate was 
roughly drawn to include neutrophils and eosinophils and exclude macrophages 
and lymphocytes (G, plots in “total cells” row).  Gated granulocytes were 
separated into neutrophils and eosinophils based on their expression of CD11c 




 The severity and character of airway inflammation is evaluated commonly 
by leukocyte differential analysis of cells recovered by bronchoalveolar lavage 
(BAL).  In this study, we aimed to develop a simple, two-color flow cytometric 
scheme for differentiating the four main leukocyte subsets from within the total 
population of cells recovered from the airway by BAL.  Differential expression of 
CD11c and Gr1 (Ly6-G/C) in addition to differences in the FSC and SSC profiles 
allowed for the resolution of macrophages, neutrophils, lymphocytes, and 
eosinophils.  We also analyzed the cell surface expression of other markers 
commonly employed for leukocyte subset identification, including F4/80, CD11b, 
Siglec F, and CCR3, and decided that CD11c vs. Gr1 was the preferred 
combination for our aims.  This method allowed us to analyze large numbers of 
cells in order to accurately characterize airway inflammation in a relatively 
investigator independent manner, and the data collected is well suited for 
convincing presentation. 
 A primary goal of this study was to overcome the difficulty in differentiating 
neutrophils and eosinophils.  In general, eosinophils have a ring-shaped nucleus 
and eosinophilic granules, while neutrophils have a polymorphonucleus and lack 
cytoplasmic granules.  However, there is considerable overlap in nuclear 
morphology, neutrophils may contain granules, and eosinophils may degranulate.  
CCR3 is the receptor for eotaxin, and CCR3 is expressed by murine 
eosinophils4.  In another study with similar aims to the present one, CCR3 was 
selected as the identifying marker for eosinophils5.  In our study, eosinophils 
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uniformly expressed CCR3.  However, the level of expression of CCR3 by 
eosinophils was relatively low, and expression of CCR3 by eosinophils 
overlapped with that of neutophils.  This was potentially problematic because 
neutrophils and eosinophils also overlapped for CD11c, FSC, and SSC.  Siglec F 
was reported as a useful marker to identify eosinophils6.  In the present study, 
eosinophils uniformly expressed high levels of Siglec F, while neutrophils 
expressed moderate levels of Siglec F.  Lymphocytes did not express Siglec F, 
but nonetheless the lymphocytes did overlap with the neutrophil population for 
Siglec F expression.  This was potentially problematic because lymphocytes and 
neutrophils also overlapped for CD11c, FSC, and SSC.  So, neutrophils could not 
be distinguished from lymphocytes or eosinophils based on FSC vs. SSC profile, 
but neutrophils could be distinguished from lymphocytes and eosinophils based 
on Gr1 expression.  In addition, lymphocytes and eosinophils did not exhibit 
overlapping SSC profiles, so a unique identifying marker for eosinophils was not 
necessary. 
 It is difficult to differentiate activated lymphocytes from monocytes due to 
similarities in size and appearance.  Generally speaking, monocytes are blood-
borne cells that rapidly differentiate into macrophages or dendritic cells when the 
migrate into peripheral tissues7.  Macrophages exhibit impressive tissue-specific 
heterogeneity8.   The cell surface molecules CD11b and F4/80 are commonly 
used as macrophage-specific markers.  However, in the alveolar compartment 
macrophages were CD11blowF4/80lowCD11chighautofluorescenthigh9.  
Macrophages in the present study had a similar appearance.  In contrast, 
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lymphocytes were CD11c-Gr1-autofluorescentlowSSClowFSClow-int, and thus, 
lymphocytes were easily distinguished from monocytes/macrophages.  CD4+ and 
CD8 + T cells and CD19+ B cells were contained entirely within the lymphcyte 
gated population (data not shown).  NK1.1+ cells, NK cells and NKT cells, 
constituted less than 1% of the total cell population (data not shown). 
 In most tissues, CD11c is a unique indentifier of dendritic cells.  In the 
alveolar compartment macrophages and dendritic cells cannot be distinguished 
by CD11c expression.  However, macrophages are autofluorescenthigh and 
dendritic cells are autofluorescentlow9.  Furthermore, dendritic cells generally 
express higher levels of MHCII and co-stimulatory receptors.  We evaluated 
dendritic cells and macrophages in the BAL samples obtained from mice 
exposed several times to A. fumigatus (data not shown).  In agreement with 
Osterholzer et al., we determined that dendritic cells are optimally identified by 
utilizing three fluorescent channels for CD11c, MHCII, and autofluorescence.  
Dendritic cells were present in the airway, but consitituted less than 5% of the 
total cells.  The majority of the CD11c+MHCII+ dendritic cells were also Gr1-, and 
therefore, they were not included in the macrophage gated population (data not 
shown).  Gr1+CD11c+MHCII+ dendritic cells that may be included in the 
macrophage gate represented a negligible percentage of the macrophage 
population (data not shown).  That does not mean that the activity of these cells 
was negligible in the airway inflammatory response, just that the presence of 
these cells did not alter the determination of macrophage numbers in a 
meaningful way.   
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 As in the present study, a previous report demonstrated that sorted Gr1high 
cells were predominantly neutrophils10.  We detected three discernable 
populations on the FSC vs. SSC plot that was contained within the homogeneous 
Gr1highCD11clow neutrophil gate.  There were no obvious disparities in the 
cytological appearances of the three populations.  For instance, immature 
neutrophil band cells were not confined to one population.  Also, granulated 
neutrophils were not observed in any sorted neutrophil population.  Recently, 
three distinct neutrophil subsets with separate functional characteristics were 
identified in the context of infection with methicillin-resistant Staphylococcus 
aureus11.  In response to A. fumigatus conidia, the three populations of 
neutrophils were invariably present regardless of the number of exposures to 
conidia or of the deficiency for critical cytokines.  Thus, it was not apparent that 
the three populations of neutrophils in this study represented functionally distinct 
populations. 
 Gr1+ blood monocytes migrate into tissues under inflammatory conditions, 
and quickly differentiate12.  Blood monocytes also express CD11b and F4/80 in 
mice.  In the present study, monocyte/macrophage gated cells expressed little to 
no CD11b and F4/80.  On the otherhand, splenic macrophages expressed both 
CD11b and F4/80 (data not shown).  So, these data imply that Gr1+ inflammatory 
monocytes recruited to the airway during the inflammatory response to A. 
fumigatus conidia likely differentiate rapidly into Gr1-CD11c+ cells, and 
Gr1+CD11c- or Gr1+CD11c+ monocyte/macrophages are likely a very small 
population at any given time.   
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 Eosinophil degranulation would affect the cytological appearance of the 
cells, but it remains controversial as to whether murine eosinophils regularly 
degranulate in allergic airway disease13, 14.  The high SSC profile of eosinophils is 
related to the presence of intracellular granules, so degranualtion may also be 
expected to reduce SSC height.  In the present study, the eosinophil population 
was a distinct population of FSClowSSCint-high cells with a single central density 
apparent on density plots.  There was no evidence of a second population 
density that might represent degranulated eosinophils.  The sorted eosinophil 
population was 99% pure.  The few eosinophils that were sorted with the 
lymphocyte population at a lower SSC height had a level of granularity similar to 
the eosinophil-gated cells .  Nonetheless, under cytological evaluation 
heterogeneity in the extent of eosinophil granularity was appreciated.  So, 
degranulation may have been involved in the allergic response, but degranulation 
did not affect the flow cytometric identification of eosinophils. 
 In this study, we developed a simple, two-color flow cytometric scheme for 
differentiating the four main leukocyte subsets from within the total population of 
BAL cells recovered from the allergic airway.  Differential expression of CD11c 
and Gr1 (Ly6-G/C) in addition to differences in the FSC and SSC profiles allowed 
for the resolution of macrophages, neutrophils, lymphocytes, and eosinophils.  
This method is well suited for the reliable evaluation of large numbers of cells, 
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Figure A2-1.  Dose response to inhaled A. fumigatus conidia 
Cells were recovered from the airway by bronchoalveolar lavage and 




Figure A2-2.  Peak levels of TH2 cytokines coincide with the pattern of 
leukocyte recruitment.  
Cytokines present in the cell-free bronchoalveolar lavage fluid were quantified by 




Figure A2-3.  The responding T cell population has a low CD8/CD4 T cell 
ratio. 
After three exposures to conidia, cells recovered from the lung-draining lymph 
node and airway were analyzed for expression of CD4, CD8 , and CD19 on 
lymphocytes as described in the materials and methods.  The percentage of total 




Figure A2-4.  CD4+ TReg cells are recruited to the airway. 
As described in the materials and methods, cells were collected from various 
tissues (including spleen, lung draining-lymph nodes (LDLN), and airway (BAL)) 
from untreated mice and mice exposed to A. fumigatus four times (n=3 per 
group) as indicated above the figure.  Cells were pooled for analysis.  Gated 
CD4+ lymphocytes were analyzed for expression of the CD25 and Foxp3 by flow 
cytometry (see axes labels for contour plots).  Quadrants were set with isotype 
control-stained CD4+ lymphocytes (not shown) and the percentage of CD4+ 




Figure A2-5.  Anti-CD4 treatment depletes CD4+ T cells 
Depletion of CD4+ T cells after anti-CD4 treatment was confirmed by flow 
cytometry using a different anti-CD4 antibody as described in the materials and 
methods.  Depletion was >99% in the lung-draining lymph nodes (shown above) 





Figure A2-6.  CD4+ T cells are necessary for the production of a TH2 
cytokine.  
Mice in both groups were exposed to A. fumigatus three times, and not treated or 





Figure A2-7.  Magnetic isolation enriched for CD4+ T Cells 
As described in the methods, naïve CD4+ T cells were purified from the spleens 
of naïve animals, and Af-primed CD4+ T cells were purified from a pool of lung 
leukocytes and lung-draining lymph node cells harvested from mice exposed to 
conidia three times.  The graph depicts the cell populations before and after 
magnetic cell isolation, and the CD4+ lymphocyte percentage of the total cell 




Figure A2-8.  CD4+ T cells in the airway are maintained with chronic 
exposure to conidia.  
Cells were recovered from the airway by bronchoalveolar lavage and the 





Figure A2-9.  Remodeling causes lumen narrowing and occlusion of small- 
to medium-sized, but not large-sized, muscular pulmonary arteries after 
long-term, repeated exposure. 
Histological sections of lung tissues were stained with H&E.  This representative 
photomicrograph includes a medium-sized muscular artery (asterisk) and a large-
sized muscular artery (pound) adjacent to conducting airways.  Images depict the 




Figure A2-10.  Hyphal invasion is not present in remodeled arteries. 
Histological sections of lung tissues were stained with GMS.  Representative 





Figure A2-11.  Cytokine-deficient mice prevent A. fumigatus colonization in 
the lung. 
Mice were exposed to A. fumigatus once a week for eight total exposures.  
Histological sections of lung tissues were stained with GMS.  Representative 








Figure A2-12.  Absence of a TH2 response in IL-10
-/- is not likely due to 
colitis. 
A) Sections are large colon tissue was stained with H&E and representative 
images are shown.  Isolated lymphocyte aggregates (asterisks) present in 
C57BL/6 and IL-10-/- mice represent normal gut-associated lymphoid tissue with 









Figure A2-13.  IL-5-/- do not exhibit airway eosinophilia but do develop CD4+ 
TH2 cells. 
A) During the peak of allergic inflammation, airway eosinophils (gate with 
percentage of total cells) were identified by flow cytometry.  B) During chronic 
inflammation, airway CD4+ T cell production of IL-4 (gate with percentage of 





Figure A2-14.  Like C57BL/6, IL-10-/- develop severe pulmonary 
inflammation with chronic exposure to conidia. 
Mice were exposed to conidia eight times on a weekly basis.  Representative 








Figure A2-15.  Strains that do and do not develop pulmonary arterial 
remodeling contain airway CD4+ TH17 cells. 
A and B)  Airway cells were collected after various strains of mice (see labels 
above plots) were exposed to conidia 8 times on a weekly basis.  Production of 
IL-17 (and IFN  in B) by CD4+ T cells (see gates for percentage of gated CD4+ T 
cells expressing cytokine) was analyzed by intracellular flow cytometry. 
 
 
 
